obsessive-compulsive disorder: A disorder characterized by the presence of persistent and recurrent irrational thoughts (obsessions), resulting in marked anxiety and repetitive excessive behaviors (compulsions) as a way to try to decrease that anxiety.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2942 |
4. Check minimum number of eventsNone |
2942 |
5. Include endpointsNone |
2942 |
6. Filter based on genotype QC (FinnGen only) |
2942 |
Control definitions (FinnGen only)
- Control exclude
- F5_NEUROTIC
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F40-F48
- Name in latin
- Perturbatio obsessivo-compulsiva
Similar endpoints
↥List of similar endpoints to
Obsessive-compulsive disorder
based on the number of shared cases.
Similar with more cases:
- Anxiety (asthma-related co-morbidities)
- All anxiety disorders
- Neurotic, stress-related and somatoform disorders
- Anxiety disorders
- Anxiety disorders, excluding more controls
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 29148 | 16764 | 12270 |
| Only index persons | 27884 | 16218 | 11666 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.42 | 0.48 | 0.34 |
| Only index persons | 0.53 | 0.60 | 0.45 |
| Median age at first event (years) | |||
| Whole population | 24.97 | 25.04 | 24.81 |
| Only index persons | 24.80 | 24.90 | 24.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2942 | 1971 | 971 |
| Unadjusted period prevalence (%) | 0.59 | 0.67 | 0.43 |
| Median age at first event (years) | 29.65 | 28.65 | 31.69 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2614
- Matched controls
- 26141
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F32.9
ICD-10 Finland
Depressive episode, unspecified
9.6
323.0
968
1515
N06AB06
ATC
sertraline; oral
16.9
323.0
1085
1055
N05AX12
ATC
aripiprazole; systemic
23.8
323.0
668
371
N05AH03
ATC
olanzapine; systemic
23.0
323.0
759
457
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
16.4
323.0
963
895
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
14.4
323.0
631
564
N06AB10
ATC
escitalopram; oral
6.9
323.0
1223
2952
N05AX08
ATC
risperidone; systemic
24.2
323.0
787
457
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
9.4
323.0
871
1318
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
19.2
323.0
816
603
N06AB03
ATC
fluoxetine; oral
12.4
323.0
912
1083
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
757.8
323.0
835
16
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
899.0
323.0
672
10
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
1086.4
323.0
1010
15
N06AB04
ATC
citalopram; systemic
7.2
323.0
956
1929
N05BA04
ATC
oxazepam; oral
9.3
323.0
1279
2448
N06AX16
ATC
venlafaxine; oral
9.2
323.0
904
1426
F41.1
ICD-10 Finland
Generalized anxiety disorder
21.6
323.0
568
331
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
882.4
323.0
802
13
N05AH04
ATC
quetiapine; oral
18.1
323.0
1461
1705
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
16.0
319.7
546
425
N06AB05
ATC
paroxetine; oral
15.9
319.3
546
426
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
20.0
313.0
488
297
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
9.4
299.9
684
953
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
9.1
299.9
697
1003
F29
ICD-10 Finland
Unspecified nonorganic psychosis
17.7
289.3
472
322
N06AX11
ATC
mirtazapine; oral
5.0
276.0
1162
3609
N05AB03
ATC
perphenazine; systemic, rectal
25.2
263.2
378
174
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
18.0
259.5
419
274
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
20.4
243.6
375
213
N03AX09
ATC
lamotrigine; oral
12.1
238.2
459
451
N06AX12
ATC
bupropion; oral
9.1
227.1
515
683
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
18.9
223.4
353
214
N06AA04
ATC
clomipramine; systemic
57.5
222.9
264
51
N05BA01
ATC
diazepam; systemic, rectal
7.1
209.4
564
969
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
19.4
209.3
327
191
F40.1
ICD-10 Finland
Social phobias
26.9
199.4
280
116
P01
ICPC
Feeling anxious/nervous/tense
4.6
195.6
826
2400
C07AA05
ATC
propranolol; systemic
4.5
193.1
834
2472
P74
ICPC
Anxiety disorder/anxiety state
10.5
187.6
388
428
N05AA02
ATC
levomepromazine; systemic
18.3
184.3
294
180
N05BA12
ATC
alprazolam; oral
7.6
178.1
451
696
IGY02
NOMESCO Finland
Psychiatric monitoring contact
20.5
176.6
270
146
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
19.3
176.2
275
158
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
21.3
173.6
262
136
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
33.9
172.1
227
73
F42
ICD-10 Finland
Obsessive-compulsive disorder
190.8
172.1
178
10
N03AG01
ATC
valproic acid; systemic, rectal
8.7
167.3
385
508
T36
ICD-10 Finland
Poisoning by systemic antibiotics
11.5
166.3
325
318
F61.0
ICD-10 Finland
Mixed personality disorders
34.3
163.5
215
68
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
23.7
163.4
238
110
F41.00
ICD-10 Finland
Moderate panic disorder
100.5
162.4
178
19
IGY99
NOMESCO Finland
Other psychiatric treatment contact
20.6
159.6
243
129
N05AF03
ATC
chlorprothixene; systemic
22.6
158.9
235
114
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
12.6
158.4
296
263
SPAT1240
SPAT
Therapeutic discussion
4.3
157.1
690
2020
N05BE01
ATC
buspirone; oral
23.6
155.7
227
105
F34.1
ICD-10 Finland
Dysthymia
13.2
147.2
268
224
N05AN01
ATC
lithium; oral
17.8
145.2
233
143
N05BA06
ATC
lorazepam; systemic, sublingual
13.4
144.8
262
216
N05CF01
ATC
zopiclone; oral
3.7
144.7
791
2775
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
14.6
144.2
251
189
P29
ICPC
Psychological sympt/compl other
5.6
139.9
449
932
P79
ICPC
Phobia/compulsive disorder
49.0
139.6
170
37
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
35.9
139.3
181
54
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
12.4
139.2
261
232
N03AE01
ATC
clonazepam; systemic
10.5
138.7
283
298
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
19.1
134.5
210
119
P76
ICPC
Depressive disorder
5.7
131.4
412
827
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
23.7
130.9
190
86
F43.1
ICD-10 Finland
Post-traumatic stress disorder
18.6
128.7
203
118
F41.09
ICD-10 Finland
UNS Panic Syndrome
15.6
128.0
216
150
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
26.0
127.5
180
74
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
15.5
125.4
212
148
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
18.7
121.0
190
109
N05AH02
ATC
clozapine; systemic
13.3
120.3
217
176
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
18.4
118.3
187
109
P99
ICPC
Psychological disorders other
11.0
117.9
234
232
N05CD07
ATC
temazepam; oral
6.8
117.2
315
514
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
15.8
115.8
194
132
F60.9
ICD-10 Finland
Personality disorder, unspecified
28.3
112.5
155
58
N06AX21
ATC
duloxetine; oral
5.0
111.7
394
896
N03AX16
ATC
pregabalin; oral
3.6
111.4
599
2016
F41.8
ICD-10 Finland
Other specified anxiety disorders
10.2
110.7
228
242
N06AX26
ATC
vortioxetine; oral
5.7
107.7
333
649
N06AB08
ATC
fluvoxamine; oral
16.0
104.1
173
115
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
12.3
103.4
193
168
F99
ICD-10 Finland
Mental disorder, not otherwise specified
13.6
99.8
178
140
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
27.4
99.4
138
53
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
16.5
99.2
163
105
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
27.7
99.0
137
52
F20.9
ICD-10 Finland
Schizophrenia, unspecified
12.3
98.5
184
160
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
33.9
98.1
129
40
N05AD01
ATC
haloperidol; systemic
14.8
97.3
167
120
F42.8
ICD-10 Finland
Other obsessive-compulsive disorders
490.3
96.0
95
*
P03
ICPC
Feeling depressed
3.4
96.0
529
1792
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
6.9
94.6
250
395
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
14.8
94.5
162
116
F60.5
ICD-10 Finland
Anankastic personality disorder
23.3
91.4
133
60
N06AX05
ATC
trazodone; oral
13.6
91.2
162
126
F31.8
ICD-10 Finland
Other bipolar affective disorders
12.7
88.9
163
136
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
11.8
87.5
166
149
N07BB01
ATC
disulfiram; oral
7.5
86.2
214
308
30030
ICD-8 Finland
Neuroses, Obsessive compulsive neurosis
+∞
85.9
82
*
SPAT1307
SPAT
Psychosocial counselling and guidance
3.4
84.4
458
1516
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.7
84.3
260
500
IGV01
NOMESCO Finland
Psychiatric network contact
27.5
83.8
116
44
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
10.8
83.6
166
163
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
17.1
83.6
135
83
N06AX03
ATC
mianserin; oral
9.9
83.3
173
185
N04AA02
ATC
biperiden; systemic
14.7
80.4
138
99
N06AG02
ATC
moclobemide; oral
9.2
80.0
174
202
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
15.2
79.9
135
93
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
206.2
77.7
80
*
F41.3
ICD-10 Finland
Other mixed anxiety disorders
13.6
77.2
137
106
AA400
NOMESCO Finland
Electroconvulsive therapy
29.7
76.1
103
36
F39
ICD-10 Finland
Unspecified mood [affective] disorder
10.4
75.3
152
154
IBA03
NOMESCO Finland
Psychotherapy evaluation
24.0
73.7
106
46
F50.9
ICD-10 Finland
Eating disorder, unspecified
11.4
71.3
137
126
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
11.6
70.8
135
122
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
11.6
69.8
133
120
F90.0
ICD-10 Finland
Disturbance of activity and attention
5.2
69.1
226
463
N06AX22
ATC
agomelatine; oral
9.5
68.5
145
160
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
22.8
67.9
99
45
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
8.7
67.6
151
183
F21
ICD-10 Finland
Schizotypal disorder
27.5
67.4
93
35
N05AF01
ATC
flupentixol; systemic
22.8
66.6
97
44
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
6.6
64.9
174
278
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
14.6
64.8
111
79
F22.0
ICD-10 Finland
Delusional disorder
18.5
64.1
100
56
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
6.4
64.0
176
291
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
15.5
63.5
106
71
N05AE04
ATC
ziprasidone; systemic
23.3
62.2
90
40
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
31.3
61.5
82
27
N06AA12
ATC
doxepin; systemic
7.3
61.0
153
222
F41.01
ICD-10 Finland
Severe panic disorder
314.8
60.6
61
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.6
60.1
295
889
N06BA04
ATC
methylphenidate; oral
5.6
59.2
182
346
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.1
59.1
246
643
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
10.1
58.8
120
124
F10.20
ICD-10 Finland
Alcohol dependence currently independent
12.5
58.4
107
89
N05CF02
ATC
zolpidem; oral
2.7
58.0
454
1889
A06AD11
ATC
lactulose; oral
3.6
57.5
285
865
F50.0
ICD-10 Finland
Anorexia nervosa
11.2
57.5
111
103
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
25.3
57.4
81
33
F32.1
ICD-10 Finland
Moderate depressive episode
3.7
57.3
274
807
A06AC01
ATC
ispaghula (psylla seeds); oral
2.6
56.7
495
2188
R53
ICD-10 Finland
Malaise and fatigue
2.4
56.6
551
2584
3003A
ICD-9 Finland
Neurotic disorders, Obsessive-compulsive disorders
+∞
56.4
54
*
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
197.6
56.2
58
*
F93.89
ICD-10 Finland
Other childhood emotional disorders
11.2
55.5
107
99
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.3
55.5
311
1037
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
27.9
55.4
76
28
F31
ICD-10 Finland
Bipolar affective disorder
12.3
55.3
102
86
P72
ICPC
Schizophrenia
8.7
54.8
122
147
188
Kela drug reimbursment
Psychosis requiring demanding treatment
14.8
54.8
93
65
A02BC02
ATC
pantoprazole; systemic
1.9
54.6
1310
8991
F32
ICD-10 Finland
Depressive episode
3.9
53.1
237
658
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
6.7
52.2
138
216
N06AA09
ATC
amitriptyline; systemic
4.3
52.0
204
503
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
22.7
51.6
75
34
F84.5
ICD-10 Finland
Asperger syndrome
15.3
51.4
86
58
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
48.8
51.3
62
13
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
24.2
51.2
73
31
IER01
NOMESCO Finland
Psychoeducation, group
19.6
51.1
78
41
SPAT1234
SPAT
Support of social functional capacity
6.3
50.9
141
235
Z71.8
ICD-10 Finland
Other specified counselling
2.1
50.4
738
4155
P06
ICPC
Sleep disturbance
2.9
50.0
335
1259
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
49.7
991
6285
N05AL01
ATC
sulpiride; systemic
14.7
48.9
83
58
L17
ICPC
Foot/toe symptom/complaint
2.1
48.1
634
3398
F51.0
ICD-10 Finland
Nonorganic insomnia
2.5
47.9
429
1908
IEY01
NOMESCO Finland
Psychoeducation, individual
16.6
47.0
76
47
A04
ICPC
Weakness/tiredness general
2.5
47.0
436
1973
M79.6
ICD-10 Finland
Pain in limb
2.0
46.6
795
4730
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
21.1
45.8
68
33
C07AB07
ATC
bisoprolol; oral
2.1
45.7
653
3612
N06AA06
ATC
trimipramine; systemic
9.4
45.6
96
105
N05AC02
ATC
thioridazine; oral
7.1
44.9
113
165
R06.0
ICD-10 Finland
Dyspnoea
2.3
44.8
494
2434
IEV99
NOMESCO Finland
Other psychiatric network intervention
26.4
44.7
62
24
N05BA02
ATC
chlordiazepoxide; systemic
11.4
44.6
85
77
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
44.6
1992
16378
N05AA01
ATC
chlorpromazine; systemic, rectal
14.5
44.1
75
53
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
6.4
43.2
117
189
X78
ICD-10 Finland
Intentional self-harm by sharp object
19.3
43.2
66
35
F60.8
ICD-10 Finland
Other specific personality disorders
21.1
43.2
64
31
R4140
NOMESCO Finland
Psychotherapy
18.1
42.9
67
38
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
9.0
42.7
92
105
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
35.1
42.6
55
16
H03AA01
ATC
levothyroxine sodium; systemic
2.2
42.4
515
2646
R42
ICD-10 Finland
Dizziness and giddiness
2.4
42.0
406
1869
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
18.0
41.5
65
37
N17
ICPC
Vertigo/dizziness
2.9
41.5
282
1063
SPAT1243
SPAT
Psychiatric/psychological examination
4.0
41.1
172
449
SPAT1301
SPAT
No procedures
1.9
41.1
802
4966
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.4
40.8
395
1817
F40.2
ICD-10 Finland
Specific (isolated) phobias
17.7
40.7
64
37
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
40.3
1326
9713
F33.8
ICD-10 Finland
Other recurrent depressive disorders
14.9
39.9
67
46
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
12.8
39.5
71
57
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
39.4
1403
10491
F50.1
ICD-10 Finland
Atypical anorexia nervosa
11.9
39.3
73
63
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
39.0
857
5504
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
32.5
38.9
51
16
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
63.9
38.2
44
7
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
20.1
37.9
57
29
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
33.3
37.6
49
15
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
22.9
37.5
54
24
R51.80
ICD-10 Finland
Headache
2.1
37.4
467
2415
S29
ICPC
Skin symptom/complaint other
2.2
37.0
421
2086
P28
ICPC
Limited function/disability (P)
15.2
36.7
61
41
G44.2
ICD-10 Finland
Tension-type headache
2.3
36.7
376
1773
F41.08
ICD-10 Finland
Mild or other specified panic syndrome
24.7
36.2
51
21
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
44.7
36.0
44
10
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
12.1
35.9
66
56
F28
ICD-10 Finland
Other nonorganic psychotic disorders
25.4
35.8
50
20
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
10.4
35.8
71
70
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
18.7
35.8
55
30
P15
ICPC
Chronic alcohol abuse
6.0
35.8
101
173
F33
ICD-10 Finland
Recurrent depressive disorder
5.8
35.7
104
185
F32.8
ICD-10 Finland
Other depressive episodes
8.4
35.7
80
98
IGY02
SPAT
NA
16.0
35.6
58
37
F61
ICD-10 Finland
Mixed and other personality disorders
28.7
35.6
48
17
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
28.7
35.6
48
17
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
4.4
35.2
132
311
AA1AD
NOMESCO Finland
CT of head and brain
2.3
35.1
368
1753
L03
ICPC
Low back symptom/complaint
1.9
35.0
605
3550
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.2
34.9
196
646
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
34.9
293
1246
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
8.1
34.9
80
102
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
13.9
34.8
60
44
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
34.2
504
2779
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.0
34.1
144
379
F60.7
ICD-10 Finland
Dependent personality disorder
65.9
34.1
39
6
N03AX12
ATC
gabapentin; oral
2.5
34.0
291
1249
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
18.9
34.0
52
28
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
33.9
1081
7701
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.8
33.6
73
85
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
11.1
33.5
64
59
N05AE05
ATC
lurasidone; oral
22.2
33.1
48
22
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
32.9
661
4074
P27
ICPC
Fear of mental disorder
7.6
32.9
78
105
IGP01
NOMESCO Finland
Psychiatric family contact
10.2
32.6
65
65
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
49.4
32.5
39
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
32.5
841
5612
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
32.5
440
2342
K59.09
ICD-10 Finland
Constipation, unspecified
4.2
32.4
129
322
SPAT1260
SPAT
Consultation of another employee
2.1
32.3
442
2360
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
14.0
32.1
55
40
WX110
NOMESCO Finland
Local anesthesy
1.7
32.1
1853
15449
G47.3
ICD-10 Finland
Sleep apnoea
2.1
32.0
387
1961
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.2
31.8
355
1735
N03AF01
ATC
carbamazepine; oral, rectal
4.5
31.7
115
262
P98
ICPC
Psychosis NOS/other
10.7
31.4
61
58
P80
ICPC
Personality disorder
18.8
31.4
48
26
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.4
31.2
157
479
T82
ICPC
Obesity
3.9
31.1
135
364
Z72.8
ICD-10 Finland
Other problems related to lifestyle
14.2
31.1
53
38
A02BC03
ATC
lansoprazole; oral
2.0
31.1
483
2709
F10.09
ICD-10 Finland
Alcohol intoxication UNS
5.9
30.9
88
153
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
30.8
314
1470
F41
ICD-10 Finland
Other anxiety disorders
6.1
30.7
86
146
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
29.7
30.7
41
14
A02BC05
ATC
esomeprazole; systemic
1.7
30.5
746
4874
EBA00
NOMESCO Finland
Extraction of tooth
1.7
30.5
932
6503
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
11.2
30.5
58
53
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.4
30.5
285
1280
P16
ICPC
Acute alcohol abuse
7.5
30.4
73
100
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
12.8
30.3
54
43
D01
ICPC
Abdominal pain/cramps general
2.1
29.9
370
1891
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
15.1
29.6
49
33
S18
ICPC
Laceration/cut
1.7
29.5
799
5371
L01
ICPC
Neck symptom/complaint
2.1
29.4
356
1800
F50.2
ICD-10 Finland
Bulimia nervosa
8.9
29.4
63
72
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
16.5
29.3
47
29
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
29.3
165
544
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
29.2
198
742
KMAK
NOMESCO Finland
NA
1.6
28.8
1388
10866
N05AD03
ATC
melperone; systemic
19.8
28.7
43
22
N05AB01
ATC
dixyrazine; systemic
16.9
28.4
45
27
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
9.7
28.4
58
61
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
10.6
28.2
55
53
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.3
28.2
146
455
N06AX18
ATC
reboxetine; oral
10.2
28.2
56
56
R35
ICD-10 Finland
Polyuria
3.6
28.2
131
375
A28
ICPC
Limited function/disability NOS
3.0
28.2
171
594
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.6
28.1
132
381
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.6
28.0
73
113
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
27.9
376
1988
F45.8
ICD-10 Finland
Other somatoform disorders
2.4
27.8
250
1098
N03AF02
ATC
oxcarbazepine; oral
4.4
27.7
104
246
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
27.6
157
523
SPAT1241
SPAT
Extensive assessment of psychosocial situation
5.3
27.6
86
167
A02BA02
ATC
ranitidine; systemic
2.2
27.6
293
1397
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
25.7
27.5
38
15
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
10.0
27.4
55
56
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
27.1
1152
8690
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
27.1
1456
11630
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.0
26.9
406
2241
F60.0
ICD-10 Finland
Paranoid personality disorder
32.2
26.8
35
11
F43.29
ICD-10 Finland
Adaptation disorder UNS
6.7
26.8
69
105
K02.1
ICD-10 Finland
Caries of dentine
1.6
26.7
1610
13201
F10.24
ICD-10 Finland
Alcohol depence active use
9.8
26.7
54
56
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.1
26.4
337
1739
R02
ICPC
Shortness of breath/dyspnoea
2.3
26.3
263
1219
A29
ICPC
General symptom/complaint other
2.4
26.1
243
1084
G04BD04
ATC
oxybutynin; oral, transdermal
3.9
26.0
109
286
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
31.3
25.9
34
11
N03AX11
ATC
topiramate; oral
4.0
25.8
106
273
R05
ICPC
Cough
1.8
25.7
563
3529
F50.3
ICD-10 Finland
Atypical bulimia nervosa
13.1
25.6
45
35
Z91.5
ICD-10 Finland
Personal history of self-harm
33.4
25.6
33
10
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.5
25.5
56
67
WX290
NOMESCO Finland
Other blockade of nerve
1.5
25.4
1357
10752
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.5
25.3
66
103
N05AE03
ATC
sertindole; oral
19.3
25.2
38
20
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
25.2
1086
8170
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
25.2
233
1038
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
25.1
448
2620
D12
ICPC
Constipation
4.9
25.1
84
177
L28
ICPC
Limited function/disability (L)
2.4
25.0
220
952
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
+∞
25.0
24
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
25.0
273
1314
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.1
25.0
293
1458
N76.0
ICD-10 Finland
Acute vaginitis
2.3
24.9
251
1163
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
70.6
24.8
28
*
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
19.7
24.8
37
19
T90
ICPC
Diabetes non-insulin dependent
2.1
24.7
289
1437
R5599
NOMESCO Finland
Other rehabilitation service
4.6
24.6
86
190
F40.8
ICD-10 Finland
Other phobic anxiety disorders
24.6
24.4
34
14
A02BC01
ATC
omeprazole; systemic
1.8
24.4
486
2951
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
22.1
24.3
35
16
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
12.1
24.2
44
37
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
24.2
311
1607
S21
ICPC
Skin texture symptom/complaint
2.1
24.2
288
1441
RS220
NOMESCO Finland
NA
7.4
24.2
58
80
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
24.0
859
6153
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
10.6
23.8
46
44
N01
ICPC
Headache
1.8
23.7
456
2730
D11
ICPC
Diarrhoea
1.9
23.5
363
2013
R03AC02
ATC
salbutamol; inhalant
1.5
23.5
1250
9820
N06BA12
ATC
lisdexamfetamine; oral
11.8
23.5
43
37
E0000UV
ATC
NA
1.5
23.4
998
7447
R12
ICD-10 Finland
Heartburn
2.7
23.3
172
676
D06
ICPC
Abdominal pain localized other
2.2
23.3
243
1147
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
23.2
372
2091
R11
ICD-10 Finland
Nausea and vomiting
2.4
23.2
214
948
R52.9
ICD-10 Finland
Pain, unspecified
2.5
23.2
191
799
A27
ICPC
Fear of other disease NOS
3.3
23.2
122
386
RT250
NOMESCO Finland
NA
28.5
23.2
31
11
SPAT1310
SPAT
Counselling related to known health issue
1.6
23.1
817
5822
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
36.6
23.0
29
8
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
22.9
548
3511
M79.7
ICD-10 Finland
Fibromyalgia
3.9
22.9
95
248
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
17.7
22.6
35
20
SPAT1389
SPAT
Visit based on need for special support
2.6
22.6
168
662
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
22.6
526
3340
U02
ICPC
Urinary frequency/urgency
2.0
22.6
307
1622
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
23.1
22.6
32
14
N05AF05
ATC
zuclopenthixol; systemic
9.2
22.5
47
52
H81
ICPC
Excessive ear wax
2.2
22.5
242
1156
A10BA02
ATC
metformin; oral
1.9
22.5
359
2016
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
22.4
878
6402
L02
ICPC
Back symptom/complaint
2.1
22.3
265
1323
P18
ICPC
Medication abuse
13.8
22.3
38
28
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
27.6
22.2
30
11
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.2
22.2
120
387
RS210
NOMESCO Finland
NA
18.1
22.2
34
19
D09
ICPC
Nausea
2.4
22.2
205
912
G04BD12
ATC
mirabegron; oral
3.0
22.1
132
455
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
22.0
150
562
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
22.0
670
4584
SPAT1254
SPAT
Administration of medicine
1.9
22.0
386
2237
H13
ICPC
Plugged feeling ear
2.0
21.9
315
1696
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.1
21.8
124
413
N05AC01
ATC
periciazine; systemic
25.3
21.7
30
12
Z00.0
ICD-10 Finland
General medical examination
1.8
21.6
452
2773
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
21.5
432
2617
A06AC51
ATC
ispaghula, combinations; systemic
3.2
21.5
116
374
ICA04
NOMESCO Finland
Psychiatric treatment plan, psychotherapy supported by Social Insurance Institution
16.4
21.4
34
21
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
21.4
1461
12016
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
26.6
21.3
29
11
F20.8
ICD-10 Finland
Other schizophrenia
20.9
21.2
31
15
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
21.2
1869
16231
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
11.6
21.2
39
34
F45.0
ICD-10 Finland
Somatization disorder
50.4
21.1
25
5
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
34.1
21.1
27
8
R4110
NOMESCO Finland
Physiotherapy
1.7
21.1
474
2972
F20
ICD-10 Finland
Schizophrenia
11.3
20.9
39
35
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
19.6
20.8
31
16
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
4.2
20.8
80
195
F34.0
ICD-10 Finland
Cyclothymia
21.7
20.8
30
14
Z01.7
ICD-10 Finland
Laboratory examination
2.1
20.7
260
1326
R20.2
ICD-10 Finland
Paraesthesia of skin
2.5
20.7
167
692
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
15.0
20.7
34
23
P01AB01
ATC
metronidazole; oral, rectal
1.5
20.6
802
5810
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.5
20.6
98
287
Z01.2
ICD-10 Finland
Dental examination
1.5
20.6
1148
9011
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
20.6
393
2339
N06AX17
ATC
milnacipran; oral
9.1
20.6
43
48
A01
ICPC
Pain general/multiple sites
2.5
20.5
165
680
U07
ICPC
Urine symptom/complaint other
3.0
20.5
123
426
L12
ICPC
Hand/finger symptom/complaint
1.8
20.5
365
2125
E66.01
ICD-10 Finland
Obesity due to excess calories
2.2
20.4
221
1060
UJF32
NOMESCO Finland
Coloscopy
1.8
20.4
388
2307
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
22.5
20.4
29
13
S06.0
ICD-10 Finland
Concussion
2.0
20.2
269
1407
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
13.1
20.2
35
27
H01
ICPC
Ear pain/earache
1.8
20.2
352
2033
M79.1
ICD-10 Finland
Myalgia
1.9
20.1
298
1624
L04
ICPC
Chest symptom/complaint
2.6
20.1
147
577
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.6
20.1
569
3805
F50.8
ICD-10 Finland
Other eating disorders
9.4
20.1
41
44
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
17.4
20.0
31
18
XKD00
NOMESCO Finland
Uroflowmetry
2.4
19.9
177
771
IEY03
NOMESCO Finland
Vocational rehabilitation
18.9
19.9
30
16
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
19.8
252
1293
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
+∞
19.8
19
*
R96
ICPC
Asthma
2.3
19.7
183
816
G43.9
ICD-10 Finland
Migraine, unspecified
2.2
19.6
210
998
IEP99
NOMESCO Finland
Other psychiatric family intervention
13.9
19.5
33
24
K59.1
ICD-10 Finland
Functional diarrhoea
2.9
19.4
120
425
R4190
NOMESCO Finland
Nutritional therapy
3.3
19.4
99
307
TKC20
NOMESCO Finland
Catheterisation of bladder
3.1
19.4
108
357
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
9.2
19.3
40
44
J02AC01
ATC
fluconazole; systemic
1.5
19.3
911
6872
N05CD02
ATC
nitrazepam; oral
11.0
19.2
36
33
M54.5
ICD-10 Finland
Low back pain
1.6
19.2
708
5052
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
19.1
188
863
R00.2
ICD-10 Finland
Palpitations
2.3
19.1
177
789
XA820
NOMESCO Finland
NA
22.7
19.0
27
12
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.9
19.0
62
128
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
14.1
19.0
32
23
Z07
ICPC
Education problem
5.1
19.0
60
120
IDY04
NOMESCO Finland
Systematic individual therapy, dialectical behaviour therapy (DBT)
55.4
18.9
22
*
Z00.8
ICD-10 Finland
Other general examinations
2.2
18.9
194
907
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
4.1
18.8
74
185
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
18.8
344
2016
S22
ICPC
Nail symptom/complaint
2.7
18.8
132
507
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
21.0
18.6
27
13
UKC02
NOMESCO Finland
Cystoscopy
2.2
18.6
196
927
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.2
18.5
186
861
A11
ICPC
Chest pain NOS
2.7
18.5
129
491
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
8.4
18.4
40
48
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
9.6
18.4
37
39
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
18.3
270
1466
C07AB02
ATC
metoprolol; systemic
2.1
18.2
227
1153
F60.1
ICD-10 Finland
Schizoid personality disorder
17.7
18.2
28
16
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
18.2
456
2938
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
18.1
382
5689
H29
ICPC
Ear symptom/complaint other
2.1
18.0
206
1011
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
18.0
786
5808
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
8.1
18.0
40
50
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
33.1
18.0
23
7
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.2
17.9
187
881
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
17.9
414
2607
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
26.9
17.8
24
9
OAB43
SPAT
NA
0.6
17.8
256
4178
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
18.2
17.8
27
15
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
+∞
17.7
17
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.2
17.7
186
880
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.8
17.7
113
409
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
17.7
384
2374
WZA90
NOMESCO Finland
Other doctors statement
1.6
17.6
619
4347
K04.1
ICD-10 Finland
Necrosis of pulp
2.0
17.5
247
1320
U05
ICPC
Urination problems other
3.5
17.5
84
249
S10
ICPC
Boil/carbuncle
2.5
17.5
137
559
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
17.0
17.4
27
16
SPAT1235
SPAT
Mental health, emotional support
7.6
17.4
40
53
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.1
17.3
54
107
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
13.9
17.3
29
21
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
13.9
17.3
29
21
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.8
17.2
291
1658
K59.0
ICD-10 Finland
Constipation
2.8
17.2
114
422
R13
ICD-10 Finland
Dysphagia
2.9
17.1
106
377
K85
ICPC
Elevated blood pressure
2.2
17.1
176
822
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
12.6
17.1
30
24
IDY02
NOMESCO Finland
Systematic individual therapy, cognitive
31.7
17.0
22
7
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
22.0
16.8
24
11
SPAT1139
SPAT
Nutrition survey
3.5
16.8
80
236
J01FF01
ATC
clindamycin; systemic
1.6
16.7
509
3447
F44.88
ICD-10 Finland
Other definite dissociation disorder
+∞
16.7
16
*
IEZ99
SPAT
NA
35.3
16.7
21
6
H93.1
ICD-10 Finland
Tinnitus
2.6
16.7
125
496
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.7
16.6
119
462
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
12.7
16.6
29
23
A05
ICPC
Feeling ill
1.9
16.5
265
1480
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
16.5
261
1451
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.6
16.5
454
2993
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
20.2
16.4
24
12
P86
ICPC
Anorexia nervosa/bulimia
7.0
16.4
40
58
R4120
NOMESCO Finland
Occupational therapy
2.6
16.4
125
504
Z08
ICPC
Social welfare problem
6.3
16.4
43
69
D03
ICPC
Heartburn
3.2
16.3
86
275
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
16.3
949
7409
X15
ICPC
Vaginal symptom/complaint other
2.4
16.2
141
606
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.6
16.2
117
458
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.0
16.2
226
1203
SPAT1252
SPAT
Overall medication plan or its review
2.9
16.1
99
351
SPAT1312
SPAT
General health counselling
1.4
16.1
880
6781
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
16.8
16.1
25
15
SPAT1284
SPAT
Extensive health certificate
2.9
16.0
98
345
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
16.0
402
2585
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
21.1
16.0
23
11
Z29
ICPC
Social problem NOS
3.6
16.0
73
209
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.3
16.0
82
257
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
7.5
15.9
37
50
EB1AA
SPAT
NA
2.5
15.9
124
505
N30.0
ICD-10 Finland
Acute cystitis
1.8
15.8
305
1813
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.7
15.8
109
413
3092E
ICD-9 Finland
Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]
+∞
15.6
15
*
SPAT1263
SPAT
Sampling
1.4
15.6
1033
8237
K08.80
ICD-10 Finland
Toothache NOS
2.0
15.6
210
1101
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
15.6
184
913
F43.23
ICD-10 Finland
Adaptive disorder with other mental disorder
26.4
15.6
21
8
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
15.6
439
2911
P19
ICPC
Drug abuse
5.4
15.6
46
86
N05AX16
ATC
brexpiprazole; oral
19.3
15.5
23
12
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
22.2
15.5
22
10
SPAT1285
SPAT
Provision of consultation response
2.5
15.5
122
500
XA800
NOMESCO Finland
Neuropsychological investigation
2.9
15.5
94
329
G04BD09
ATC
trospium; oral
6.2
15.4
41
67
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
15.4
318
1931
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
15.4
345
2145
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.3
15.3
147
668
K10.3
ICD-10 Finland
Alveolitis of jaws
2.4
15.3
132
567
E66.8
ICD-10 Finland
Other obesity
2.5
15.3
126
528
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
16.1
15.2
24
15
SPAT1058
SPAT
PEF monitoring instruction
2.1
15.2
166
800
SPAT1216
SPAT
Assessment of functional ability
2.0
15.2
200
1038
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
9.8
15.2
30
31
WX110
SPAT
NA
2.4
15.1
126
533
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
15.1
350
2198
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
5.7
15.1
43
77
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
20.2
15.1
22
11
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
20.2
15.1
22
11
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
15.0
667
4912
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.3
15.0
144
651
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.1
15.0
177
879
WX002
NOMESCO Finland
Sedation and analgesia
1.8
15.0
294
1760
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
4.1
14.9
57
140
R07.3
ICD-10 Finland
Other chest pain
2.1
14.9
168
819
SFA00
NOMESCO Finland
Small filling
1.8
14.9
286
1697
N05AX13
ATC
paliperidone; systemic
7.9
14.8
33
42
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
31.9
14.8
19
6
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
11.4
14.8
27
24
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
25.2
14.7
20
8
F43.00
ICD-10 Finland
Acute stress reaction mild
3.7
14.7
64
177
T74.1
ICD-10 Finland
Physical abuse
3.4
14.6
71
214
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
14.6
590
4254
Z02.7
ICD-10 Finland
Issue of medical certificate
2.3
14.6
141
640
30041
ICD-8 Finland
Neuroses, Depressiva
11.9
14.6
26
22
C03CA01
ATC
furosemide; systemic
1.9
14.5
223
1230
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
14.5
153
724
RS140
NOMESCO Finland
NA
10.9
14.5
27
25
N02BE01
ATC
paracetamol; systemic, rectal
1.4
14.4
1860
16601
IAZ99
NOMESCO Finland
Other psychiatric consultation
36.2
14.4
18
5
-1
NOMESCO Finland
NA
1.4
14.4
1000
8010
R21
ICPC
Throat symptom/complaint
1.4
14.4
730
5515
ICB03
SPAT
NA
15.4
14.4
23
15
R52.2
ICD-10 Finland
Other chronic pain
3.4
14.4
68
201
R30.0
ICD-10 Finland
Dysuria
2.8
14.3
92
334
Z63.0
ICD-10 Finland
Problems in relationship with spouse or partner
7.9
14.3
32
41
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
17.1
14.3
22
13
IHZ05
SPAT
NA
2.4
14.3
121
517
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
8.2
14.3
31
38
N04BC05
ATC
pramipexole; oral
2.7
14.2
96
360
V03AA01
ATC
NA
6.1
14.2
38
63
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
9.1
14.2
29
32
F20.10
ICD-10 Finland
Raise schizophrenia continuously
12.0
14.1
25
21
N06BA09
ATC
atomoxetine; oral
12.0
14.1
25
21
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
14.5
14.0
23
16
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.4
14.0
124
539
E000001
ATC
NA
1.5
14.0
525
3719
R60.0
ICD-10 Finland
Localized oedema
2.2
14.0
152
729
K03.66
ICD-10 Finland
Tooth plaque
2.1
13.9
168
845
H53.1
ICD-10 Finland
Subjective visual disturbances
2.4
13.8
121
526
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
13.8
237
1355
F43.25
ICD-10 Finland
Adaptive disorder with mixed mental disorder and behavioral disorder
53.6
13.8
16
*
RS221
NOMESCO Finland
NA
5.1
13.8
43
86
G04CA02
ATC
tamsulosin; oral
1.9
13.7
197
1056
SPAT1097
SPAT
Recording of ECG
1.9
13.7
193
1029
F43.02
ICD-10 Finland
Acute stress reaction severe
13.6
13.7
23
17
IHZ07
SPAT
NA
13.6
13.7
23
17
F92.0
ICD-10 Finland
Depressive conduct disorder
9.1
13.7
28
31
A97
ICPC
No disease
1.6
13.7
374
2456
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
13.6
322
2032
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
6.9
13.6
33
48
J01EA01
ATC
trimethoprim; systemic
1.5
13.6
481
3361
L15
ICPC
Knee symptom/complaint
1.6
13.6
395
2632
IDY24
NOMESCO Finland
Systematic individual treatment, dialectical behaviour therapy (DBT), pre-treatment
75.5
13.6
15
*
F20.5
ICD-10 Finland
Residual schizophrenia
12.1
13.6
24
20
F43.8
ICD-10 Finland
Other reactions to severe stress
3.4
13.6
64
189
30088
ICD-8 Finland
Neuroses, Other
+∞
13.5
13
*
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.9
13.5
195
1048
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
13.5
331
2108
F48.9
ICD-10 Finland
Neurotic disorder, unspecified
140.7
13.5
14
*
RT180
NOMESCO Finland
NA
140.7
13.5
14
*
K03.00
ICD-10 Finland
Approximal wear
2.3
13.4
121
533
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
7.5
13.4
31
42
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
12.9
13.4
23
18
H02
ICPC
Hearing complaint
2.2
13.4
133
613
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
21.2
13.3
19
9
G47.9
ICD-10 Finland
Sleep disorder, unspecified
3.4
13.3
63
187
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.9
13.2
203
1118
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
13.2
177
925
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
13.9
13.2
22
16
P73
ICPC
Affective psychosis
9.7
13.2
26
27
T05
ICPC
Feeding problem of adult
4.7
13.2
44
95
SPAT1101
SPAT
Orthostatic test
4.2
13.2
49
118
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
13.2
570
4155
E87.6
ICD-10 Finland
Hypokalaemia
4.1
13.1
50
123
F29
ICPC
Eye symptom/complaint other
1.9
13.1
189
1018
IAA02
NOMESCO Finland
Consultation concerning further psychiatric treatment
15.1
13.1
21
14
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.7
13.1
91
350
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
7.1
13.0
31
44
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
13.0
96
379
S76
ICPC
Skin infection other
2.5
13.0
106
443
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
11.0
13.0
24
22
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.0
13.0
167
861
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.8
13.0
244
1439
RT120
NOMESCO Finland
NA
16.8
13.0
20
12
N06AA22
ATC
NA
16.8
13.0
20
12
IFB02
NOMESCO Finland
Transcranial magnetic stimulation (TMS)
19.1
12.9
19
10
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
19.1
12.9
19
10
S02
ICPC
Pruritus
2.5
12.9
103
428
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.2
12.8
135
640
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
50.2
12.8
15
*
X14
ICPC
Vaginal discharge
2.5
12.8
96
385
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.6
12.8
56
156
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
4.4
12.8
45
103
Z03
ICPC
Housing/neighbourhood problem
8.5
12.7
27
32
D19
ICPC
Teeth/gum symptom/complaint
1.4
12.7
658
4968
P58
ICPC
Psychological, Therapeutic counselling/listening
3.2
12.7
66
210
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
9.7
12.7
25
26
SPAT1265
SPAT
Breathalyser
5.8
12.7
35
61
R05
ICD-10 Finland
Cough
1.6
12.7
362
2399
R74
ICPC
Upper respiratory infection acute
1.4
12.7
891
7109
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
7.5
12.7
29
39
Z71.9
ICD-10 Finland
Counselling, unspecified
2.2
12.7
134
638
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
2.6
12.6
94
374
S51.8
ICD-10 Finland
Open wound of other parts of forearm
6.2
12.6
33
54
D07AC01
ATC
betamethasone; topical
1.4
12.5
625
4686
K58
ICD-10 Finland
Irritable bowel syndrome
2.8
12.5
78
281
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
10.1
12.5
24
24
R30.1
ICD-10 Finland
Vesical tenesmus
4.6
12.5
42
92
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
20.1
12.4
18
9
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
20.1
12.4
18
9
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
12.4
171
905
N05AX15
ATC
cariprazine; oral
13.2
12.4
21
16
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
12.4
165
864
L05
ICPC
Flank/axilla symptom/complaint
2.3
12.4
113
500
X23
ICPC
Fear sexually transm dis female
1.7
12.3
250
1509
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.7
12.3
266
1638
S04
ICPC
Lump/swelling localized
1.8
12.3
229
1347
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.4
12.3
831
6582
L14
ICPC
Leg/thigh symptom/complaint
2.1
12.2
137
667
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.9
12.2
179
970
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.8
12.2
221
1285
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.9
12.2
177
957
K96
ICPC
Haemorrhoids
3.1
12.2
67
223
RD210
NOMESCO Finland
NA
3.2
12.1
63
201
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
15.9
12.1
19
12
SPAT1281
SPAT
Other administrative function
1.9
12.1
186
1023
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.9
12.1
75
268
309
Kela drug reimbursment
Nalmefene and naltrexone
12.4
12.1
21
17
-58
ICPC
Therapeutic counselling/listening
5.8
12.1
33
57
D82
ICPC
Teeth/gum disease
1.4
12.1
929
7512
A03FA02
ATC
cisapride; oral, rectal
2.3
12.1
115
523
RT150
NOMESCO Finland
NA
8.2
12.0
26
32
IEP01
NOMESCO Finland
Psychoeducation, family
18.1
12.0
18
10
RT130
NOMESCO Finland
NA
18.1
12.0
18
10
SPAT1262
SPAT
Handing over of treatment supplies
1.7
12.0
260
1598
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
12.0
164
867
N05AH05
ATC
asenapine; oral
21.4
12.0
17
8
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
12.0
90
361
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
10.1
12.0
23
23
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
12.0
288
1822
R10.2
ICD-10 Finland
Pelvic and perineal pain
3.1
11.9
64
209
G04BD07
ATC
tolterodine; oral
3.3
11.9
60
187
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
11.9
165
874
R25.1
ICD-10 Finland
Tremor, unspecified
3.6
11.9
52
145
T83
ICPC
Overweight
3.3
11.9
59
182
G04BD08
ATC
solifenacin; oral
2.8
11.9
76
279
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
46.9
11.9
14
*
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.8
11.9
206
1183
B18.2
ICD-10 Finland
Chronic viral hepatitis C
5.0
11.8
37
75
R33
ICD-10 Finland
Retention of urine
2.7
11.8
78
290
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.7
11.8
258
1589
X84
ICD-10 Finland
Intentional self-harm by unspecified means
11.7
11.8
21
18
R06.5
ICD-10 Finland
Mouth breathing
2.0
11.8
158
830
K07.60
ICD-10 Finland
Snapping jaw
2.1
11.7
136
672
K08.3
ICD-10 Finland
Retained dental root
2.3
11.7
106
467
R55
ICD-10 Finland
Syncope and collapse
2.0
11.7
155
808
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
11.7
173
942
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.7
11.7
310
4454
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
16.5
11.7
18
11
F25.80
ICD-10 Finland
Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms
30.2
11.6
15
5
IBC98
NOMESCO Finland
Other child protection assessment
19.0
11.6
17
9
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
11.6
303
1964
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
11.6
91
375
M25.5
ICD-10 Finland
Pain in joint
1.4
11.6
565
4207
IAB11
NOMESCO Finland
Psychiatric mood consultation
23.0
11.6
16
7
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.4
11.5
40
91
R63.0
ICD-10 Finland
Anorexia
10.1
11.5
22
22
3090A
ICD-9 Finland
Adjustment reaction, Brief depressive reaction
+∞
11.5
11
*
RT421
NOMESCO Finland
NA
120.5
11.4
12
*
L08
ICPC
Shoulder symptom/complaint
1.6
11.4
292
1881
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
11.4
298
1930
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
6.4
11.4
29
46
SPAT1336
SPAT
Request for examination
2.5
11.4
86
346
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.7
11.3
37
79
L29
ICPC
Musculoskeletal sympt/complt other
2.0
11.3
146
755
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
11.3
377
2589
K30
ICD-10 Finland
Functional dyspepsia
1.8
11.3
192
1096
J01DB01
ATC
cefalexin; oral
1.4
11.3
1951
17821
K62.3
ICD-10 Finland
Rectal prolapse
6.6
11.2
28
43
U13
ICPC
Bladder symptom/complaint other
3.1
11.2
60
196
F63.0
ICD-10 Finland
Pathological gambling
9.6
11.2
22
23
A99
ICPC
Disease/condition unspecnature/site
2.0
11.2
147
763
R63.4
ICD-10 Finland
Abnormal weight loss
3.1
11.2
59
191
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
5.3
11.2
33
63
A13
ICPC
Concern/fear medical treatment
5.3
11.2
33
63
A03CA02
ATC
clidinium and psycholeptics; oral
2.9
11.2
66
231
R07.0
ICD-10 Finland
Pain in throat
1.9
11.1
172
948
L13
ICPC
Hip symptom/complaint
1.8
11.1
196
1131
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
11.1
240
1476
W78
ICPC
Pregnancy
0.7
11.1
345
4814
C10AC01
ATC
colestyramine; oral
3.4
11.1
53
160
X21
ICPC
Breast sympt/compl female other
3.2
11.0
57
182
C05AA08
ATC
fluocortolone; rectal, topical
1.7
11.0
211
1250
IHZ04
SPAT
NA
7.1
11.0
26
37
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
4.7
11.0
36
77
IBZ08
NOMESCO Finland
Gender identity assessment
8.6
11.0
23
27
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
5.8
11.0
30
52
P25
ICPC
Phase of life problem adult
2.1
11.0
122
594
F31.2
ICD-10 Finland
Bipolar affective disorder, current episode manic with psychotic symptoms
13.9
11.0
18
13
IAB03
NOMESCO Finland
Neuropsychiatric consultation
43.5
10.9
13
*
IFA37
NOMESCO Finland
Ketamine treatment
43.5
10.9
13
*
F20.0
ICD-10 Finland
Paranoid schizophrenia
6.3
10.9
28
45
IHZ02
SPAT
NA
2.9
10.9
64
223
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.5
10.9
407
2870
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
10.9
542
4049
Z72.1
ICD-10 Finland
Alcohol use
5.5
10.9
31
57
N91.1
ICD-10 Finland
Secondary amenorrhoea
2.4
10.8
90
383
WX290
SPAT
NA
2.5
10.8
83
338
B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
3.1
10.8
57
185
R5140
NOMESCO Finland
Monitoring the use of the aid
2.0
10.8
142
739
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
2.5
10.8
83
339
U01
ICPC
Dysuria/painful urination
1.8
10.8
184
1051
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
10.8
129
648
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.8
10.8
182
1036
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
7.2
10.7
25
35
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
7.2
10.7
25
35
D18
ICPC
Change in faeces/bowel movements
3.3
10.7
53
164
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
17.9
10.7
16
9
T86
ICPC
Hypothyroidism/myxoedema
2.6
10.7
77
304
J01DA01
ATC
[U] cefalexin; systemic
1.3
10.7
1341
11613
E66
ICD-10 Finland
Obesity
2.3
10.7
98
439
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.6
10.7
47
133
3071A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Anorexia nervosa
21.5
10.7
15
7
2959A
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]
21.5
10.7
15
7
IAB13
NOMESCO Finland
Psychiatric sleep disorder consultation
21.5
10.7
15
7
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.7
10.7
221
1341
T07
ICPC
Weight gain
3.5
10.6
48
139
R29
ICPC
Respiratory symptom/complaint other
2.0
10.6
139
725
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
10.6
558
4211
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
11.2
10.5
19
17
S51.7
ICD-10 Finland
Multiple open wounds of forearm
9.2
10.5
21
23
N05BA05
ATC
potassium clorazepate; oral
9.2
10.5
21
23
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.9
10.5
42
110
K03.28
ICD-10 Finland
Other erosion of teeth
3.7
10.5
44
120
A91
ICPC
Abnormal result investigation NOS
2.6
10.4
74
289
ICC02
NOMESCO Finland
Psychiatric treatment plan, transfer to intensive psychiatric outpatient care
110.4
10.4
11
*
F60.4
ICD-10 Finland
Histrionic personality disorder
110.4
10.4
11
*
F43.01
ICD-10 Finland
Acute stress reaction moderate
4.0
10.4
40
101
R06AE07
ATC
cetirizine; oral
1.3
10.4
1042
8722
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
16.1
10.3
16
10
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
16.1
10.3
16
10
D10
ICPC
Vomiting
1.7
10.3
215
1308
30188
ICD-8 Finland
Personality disorders, Alia definita
32.6
10.3
13
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
8.2
10.3
22
27
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.4
10.3
570
4334
R63.1
ICD-10 Finland
Polydipsia
10.6
10.3
19
18
SPAT1238
SPAT
Brief therapy
2.7
10.2
69
262
N02AX02
ATC
tramadol; systemic, rectal
1.4
10.2
614
4735
K80
ICPC
Cardiac arrhythmia NOS
2.2
10.2
105
496
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.1
10.2
55
182
SPAT1283
SPAT
Restricted health certificate
1.4
10.2
664
5194
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.5
10.1
337
2311
C10AA01
ATC
simvastatin; oral
1.5
10.1
331
2262
183
Kela drug reimbursment
Lamotrigin and topiramate
4.0
10.1
39
99
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
10.1
113
553
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.4
10.1
81
337
J01FA06
ATC
roxithromycin; oral
1.4
10.1
731
5818
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.9
10.0
140
747
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.7
10.0
444
5841
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.7
10.0
267
3839
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
10.0
117
584
O99.80
ICD-10 Finland
The fear of childbirth
1.8
10.0
163
920
IDR02
NOMESCO Finland
Systematic group therapy, cognitive
40.2
10.0
12
*
OAB95
SPAT
NA
0.4
9.9
43
1026
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.6
9.9
300
2014
F63.8
ICD-10 Finland
Other habit and impulse disorders
16.8
9.9
15
9
E03
ICD-10 Finland
Other hypothyroidism
2.2
9.8
99
462
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
9.8
1479
13068
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
10.7
9.8
18
17
I84
ICD-10 Finland
Hemorrhoids
2.9
9.7
58
205
R60.9
ICD-10 Finland
Oedema, unspecified
2.7
9.7
66
252
E66.00
ICD-10 Finland
Metabolic syndrome
2.3
9.7
85
371
L20.0
ICD-10 Finland
Besnier prurigo
1.6
9.6
234
1487
SPAT1395
SPAT
Health check-up of persons outside student and working life
3.0
9.6
55
187
K04.08
ICD-10 Finland
Other specified pulpit
1.8
9.6
174
1014
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
9.6
105
509
S82
ICPC
Naevus/mole
1.6
9.6
267
1752
D02
ICPC
Abdominal pain epigastric
1.9
9.6
135
724
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
11.4
9.6
17
15
A01AB04
ATC
amphotericin B; local oral
2.9
9.5
56
196
J01CA08
ATC
pivmecillinam; oral
1.3
9.5
842
6895
F89
ICD-10 Finland
Unspecified disorder of psychological development
15.1
9.5
15
10
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
15.1
9.5
15
10
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
4.7
9.5
31
67
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.9
9.5
37
95
Z06
ICPC
Unemployment problem
5.7
9.5
26
46
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.6
9.5
276
1833
P20
ICPC
Memory disturbance
2.5
9.5
74
304
L18
ICPC
Muscle pain
2.2
9.5
94
437
R03BA02
ATC
budesonide; inhalant
1.5
9.4
340
2372
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
9.4
377
2690
K04.09
ICD-10 Finland
Pulpit UNS
2.1
9.4
108
534
RT230
NOMESCO Finland
NA
100.4
9.4
10
*
3012C
ICD-9 Finland
Personality disorders, Schizoid personality disorder[PSYKOOSIPIIRTEINEN PERSOONALLISUUS]
100.4
9.4
10
*
SPAT1197
SPAT
Extensive health check-up of expecting family
0.7
9.4
309
4283
F51.1
ICD-10 Finland
Nonorganic hypersomnia
30.1
9.4
12
*
3000B
ICD-9 Finland
Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]
+∞
9.4
9
*
R4110
SPAT
NA
3.1
9.4
50
165
R1250
NOMESCO Finland
Evaluation of functional capability
3.4
9.4
43
127
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.1
9.4
108
537
2959E
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]
21.8
9.3
13
6
E66.9
ICD-10 Finland
Obesity, unspecified
2.3
9.3
85
378
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
3.5
9.3
42
122
SPAT1246
SPAT
Screening of depression or other psychiatric problem
1.8
9.3
173
1015
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.8
9.3
146
813
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.4
9.3
43
128
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.4
9.2
23
36
SPAT1244
SPAT
Occupational therapy
6.4
9.2
23
36
K04
ICPC
Palpitations/awareness of heart
2.1
9.2
98
471
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.6
9.2
243
1577
T78.4
ICD-10 Finland
Allergy, unspecified
1.9
9.2
123
647
P04
ICPC
Feeling/behaving irritable/angry
4.8
9.1
29
61
D07AC13
ATC
mometasone; topical
1.4
9.1
538
4125
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.5
9.1
41
119
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
3.5
9.1
41
120
N06AE02
ATC
NA
36.8
9.0
11
*
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
10.1
9.0
17
17
SPAT1237
SPAT
Psychotherapy
3.9
9.0
35
90
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
2.2
9.0
86
394
D07AA02
ATC
hydrocortisone; topical
1.5
9.0
358
2552
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.3
8.9
43
132
SDA02
NOMESCO Finland
Parodonthologic therapy
1.3
8.9
749
6072
RS310
NOMESCO Finland
NA
18.7
8.9
13
7
29580
ICD-8 Finland
Schizophrenia, Other
24.1
8.9
12
5
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.2
8.9
88
410
EBA10
NOMESCO Finland
Surgical removal of tooth
1.4
8.9
427
3157
R44.3
ICD-10 Finland
Hallucinations, unspecified
12.6
8.9
15
12
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
8.8
191
1176
RS120
NOMESCO Finland
NA
8.0
8.8
19
24
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.7
8.8
177
1064
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
6.8
8.8
21
31
SPAT1380
SPAT
Postpartum check-up
0.7
8.8
215
3152
2954A
ICD-9 Finland
Schizophrenic psychoses, Acute schizophrenic episode
10.7
8.8
16
15
OAA80
SPAT
NA
0.4
8.8
37
889
P48
ICPC
Psychological, Clarification/discussion RFE/demand
5.9
8.7
23
39
Z61.8
ICD-10 Finland
Other negative life events in childhood
14.1
8.7
14
10
F20.6
ICD-10 Finland
Simple schizophrenia
14.1
8.7
14
10
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
14.1
8.7
14
10
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
3.1
8.7
46
152
M54.2
ICD-10 Finland
Cervicalgia
1.9
8.7
123
661
UJH02
NOMESCO Finland
Anoscopy
2.4
8.6
70
297
SPAT1379
SPAT
Health check-up of pregnant person
0.7
8.6
270
3779
R07
ICPC
Sneezing/nasal congestion
1.6
8.6
206
1302
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.8
8.6
142
806
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
5.2
8.6
25
48
N92.5
ICD-10 Finland
Other specified irregular menstruation
2.0
8.6
102
513
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
8.6
764
6239
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.3
8.6
80
361
SPAT1153
SPAT
Removal of sutures
1.4
8.6
475
3600
K03.80
ICD-10 Finland
Irradiated enamel
2.0
8.6
114
597
F13.2
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome
16.3
8.5
13
8
IFA99
SPAT
NA
16.3
8.5
13
8
30180
ICD-8 Finland
Personality disorders, Immatura
16.3
8.5
13
8
IDP99
NOMESCO Finland
Other psychotherapeutic family intervention
16.3
8.5
13
8
K03.2
ICD-10 Finland
Erosion of teeth
2.8
8.5
52
188
F95.9
ICD-10 Finland
Tic disorder, unspecified
9.0
8.5
17
19
RS214
NOMESCO Finland
NA
9.0
8.5
17
19
N89
ICPC
Migraine
1.9
8.5
124
673
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
10.1
8.5
16
16
W0A10
NOMESCO Finland
Mapping of psychosocial situation
10.1
8.5
16
16
EB1SA
SPAT
NA
2.1
8.5
97
480
L29.9
ICD-10 Finland
Pruritus, unspecified
2.9
8.5
50
176
N06AA10
ATC
nortriptyline; systemic
3.3
8.5
40
121
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
8.5
465
3517
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
8.5
456
3439
F63.3
ICD-10 Finland
Trichotillomania
27.6
8.5
11
*
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
6.4
8.5
21
33
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
8.5
96
472
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
5.6
8.4
23
41
C08CA01
ATC
amlodipine; oral
1.5
8.4
307
2147
RT280
NOMESCO Finland
NA
90.3
8.4
9
*
3138C
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[LAPSUUSIÄN RAJATILAHÄIRIÖ]
90.3
8.4
9
*
M70.6
ICD-10 Finland
Trochanteric bursitis
1.8
8.4
131
729
L16
ICPC
Ankle symptom/complaint
1.6
8.4
230
1504
K02
ICD-10 Finland
Dental caries
1.7
8.4
165
989
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
8.4
119
641
OAB38
SPAT
NA
2.2
8.4
77
348
A92
ICPC
Allergy/allergic reaction NOS
2.1
8.3
93
454
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.9
8.3
113
599
F44.4
ICD-10 Finland
Dissociative motor disorders
+∞
8.3
8
*
RT153
NOMESCO Finland
NA
+∞
8.3
8
*
30020
ICD-8 Finland
Neuroses, Phobic neurosis
+∞
8.3
8
*
K04.0
ICD-10 Finland
Pulpitis
1.5
8.3
246
1642
D01AC02
ATC
miconazole; topical
1.9
8.3
119
644
IAA01
SPAT
NA
6.2
8.3
21
34
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
8.3
120
648
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
8.3
137
777
G24.9
ICD-10 Finland
Dystonia, unspecified
9.5
8.3
16
17
L19
ICPC
Muscle symptom/complaint NOS
2.7
8.3
53
197
J20
ICD-10 Finland
Acute bronchitis
1.7
8.2
160
955
SPAT1167
SPAT
Insertion of urinary catheter
4.0
8.2
31
78
N94.1
ICD-10 Finland
Dyspareunia
2.6
8.2
58
229
C08DA01
ATC
verapamil; systemic
2.8
8.2
49
175
R44.0
ICD-10 Finland
Auditory hallucinations
14.5
8.2
13
9
A02BA03
ATC
famotidine; systemic
3.1
8.2
42
136
A02BC04
ATC
rabeprazole; oral
1.8
8.1
145
842
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.7
8.1
54
206
XJH00
NOMESCO Finland
Transanal ultrasonography
2.6
8.1
56
217
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
5.7
8.1
22
39
F61.1
ICD-10 Finland
Disturbing personality change
33.4
8.1
10
*
F30.1
ICD-10 Finland
Mania without psychotic symptoms
17.2
8.1
12
7
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
11.7
8.1
14
12
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
11.7
8.1
14
12
G72.8
ICD-10 Finland
Other specified myopathies
4.8
8.1
25
52
A08
ICPC
Swelling
2.6
8.0
55
211
IDY99
NOMESCO Finland
Other individual psychotherapy intervention
8.9
8.0
16
18
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
8.0
367
2686
F84.8
ICD-10 Finland
Other pervasive developmental disorders
10.0
8.0
15
15
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
10.0
8.0
15
15
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.9
8.0
47
166
S94
ICPC
Ingrowing nail
3.1
8.0
41
133
WX402
NOMESCO Finland
General anaesthesia
1.5
8.0
317
2258
Z73.9
ICD-10 Finland
Problem related to life-management difficulty, unspecified
4.1
8.0
29
71
R39.1
ICD-10 Finland
Other difficulties with micturition
2.9
8.0
46
160
Z50.1
ICD-10 Finland
Other physical therapy
2.2
7.9
76
350
L09
ICPC
Arm symptom/complaint
2.0
7.9
93
468
Z63.9
ICD-10 Finland
Problem related to primary support group, unspecified
13.1
7.9
13
10
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
13.1
7.9
13
10
IEV99
SPAT
NA
13.1
7.9
13
10
K14.61
ICD-10 Finland
Glossodynia
7.8
7.9
17
22
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
7.8
7.9
17
22
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.1
7.9
40
129
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
6.1
7.8
20
33
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
6.1
7.8
20
33
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.7
7.8
166
1016
G02CB01
ATC
bromocriptine; systemic
3.0
7.8
42
141
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
8.5
7.8
16
19
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
7.8
120
665
F23.29
ICD-10 Finland
Acute schizophrenia-like psychosis UNS
10.8
7.8
14
13
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
7.8
152
907
F38.8
ICD-10 Finland
Other specified mood [affective] disorders
9.4
7.8
15
16
RS230
NOMESCO Finland
NA
7.0
7.8
18
26
A02BA04
ATC
nizatidine; systemic
2.1
7.7
82
394
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.7
7.7
290
3936
S01
ICPC
Pain/tenderness of skin
2.1
7.7
84
407
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.3
7.7
36
109
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
7.7
102
537
29599
ICD-8 Finland
Schizophrenia, Unspecified type
15.1
7.7
12
8
A03
ICPC
Fever
1.4
7.7
466
3581
L84
ICPC
Back syndrome without radiat pain
2.1
7.7
84
409
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.1
7.7
79
374
WX892
NOMESCO Finland
Monitored bed care
2.0
7.7
99
514
N02AA05
ATC
oxycodone; systemic
1.8
7.7
128
728
M54.6
ICD-10 Finland
Pain in thoracic spine
1.8
7.6
135
781
N05CD08
ATC
midazolam; nasal, systemic
3.8
7.6
30
79
F20.4
ICD-10 Finland
Post-schizophrenic depression
18.4
7.6
11
6
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
7.6
749
6186
X16
ICPC
Vulval symptom/complaint
2.6
7.6
53
208
P50
ICPC
Psychological, Medication/prescr/renewal
6.7
7.6
18
27
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.6
7.6
175
1098
SPAT1053
SPAT
Memory test
2.1
7.6
81
392
R2
NOMESCO Finland
Guidance supporting rehabilitation
11.9
7.6
13
11
G40.52
ICD-10 Finland
Epileptic seizures related to drugs
25.1
7.6
10
*
RT253
NOMESCO Finland
NA
25.1
7.6
10
*
IER02
SPAT
NA
25.1
7.6
10
*
EBA00
SPAT
NA
2.6
7.6
50
191
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
7.5
267
1853
SPAT1360
SPAT
Extensive global examination
1.9
7.5
112
615
L86
ICPC
Back syndrome with radiating pain
2.0
7.5
92
471
R50.9
ICD-10 Finland
Fever, unspecified
1.5
7.5
268
1866
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.4
7.5
34
101
ZYC02
SPAT
NA
1.9
7.5
110
602
A01AB09
ATC
miconazole; local oral
1.8
7.5
130
750
R03BB04
ATC
tiotropium bromide; inhalant
2.0
7.5
91
463
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.4
7.5
477
3696
ZXA05
NOMESCO Finland
Left side
1.4
7.4
310
2226
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.3
7.4
35
107
G04BD11
ATC
fesoterodine; oral
3.2
7.4
37
118
IER01
SPAT
NA
80.3
7.4
8
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
5.0
7.4
22
44
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
6.5
7.4
18
28
G01AA10
ATC
clindamycin; vaginal
1.5
7.4
268
1870
R06AX22
ATC
ebastine; oral
1.4
7.4
340
2490
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.4
7.4
59
250
R68.2
ICD-10 Finland
Dry mouth, unspecified
7.7
7.4
16
21
P23
ICPC
Adolescent behaviour sympt/compl
4.1
7.4
27
67
U04
ICPC
Incontinence urine
2.6
7.4
51
198
R04
ICPC
Breathing problem other
2.3
7.4
64
282
T99
ICPC
Endocr/metab/nutrit disease other
3.8
7.3
29
77
C01CA24
ATC
epinephrine; parenteral
1.7
7.3
155
951
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
7.3
90
459
X29
ICPC
Genital sympt/compl female other
2.8
7.3
45
165
B80
ICPC
Iron deficiency anaemia
2.6
7.3
49
189
WZA10
SPAT
NA
2.6
7.3
51
200
SPAT1051
SPAT
Guidance regarding sleep disorders
2.7
7.3
48
183
WYA24
NOMESCO Finland
NA
+∞
7.3
7
*
3009X
ICD-9 Finland
Neurotic disorders, Unspecified neurotic disorder
+∞
7.3
7
*
3138B
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[IDENTITEETTIHÄIRIÖ]
+∞
7.3
7
*
3000C
ICD-9 Finland
Neurotic disorders, Anxiety states[YLEISTYNYT TUSKAISUUS]
+∞
7.3
7
*
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.5
7.3
257
1785
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.9
7.3
98
518
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
3.1
7.3
37
120
Z01
ICPC
Poverty/financial problem
9.4
7.3
14
15
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.6
7.3
51
201
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
4.9
7.3
22
45
IFA01
SPAT
NA
15.8
7.2
11
7
R1
NOMESCO Finland
Evaluation of the need and prospects for rehabilitation
15.8
7.2
11
7
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.1
7.2
78
378
N88
ICPC
Epilepsy
5.8
7.2
19
33
RS211
NOMESCO Finland
NA
5.8
7.2
19
33
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
7.2
193
1258
P17
ICPC
Tobacco abuse
3.1
7.2
37
121
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
7.2
196
1283
Z27
ICPC
Fear of a social problem
4.6
7.2
23
50
WX722
NOMESCO Finland
PEEP
2.5
7.2
51
203
F32.0
ICD-10 Finland
Mild depressive episode
2.2
7.2
69
320
S03
ICPC
Warts
2.4
7.2
57
240
S87
ICPC
Dermatitis/atopic eczema
2.1
7.2
73
346
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.1
7.2
36
116
RF242
NOMESCO Finland
NA
30.1
7.1
9
*
X81
ICD-10 Finland
Intentional self-harm by jumping or lying before moving object
30.1
7.1
9
*
B07.9
ICD-10 Finland
Verruca simplex
2.0
7.1
87
445
U08
ICPC
Urinary retention
4.8
7.1
22
46
SPAT1227
SPAT
Substance abuse rehabilitation
4.4
7.1
24
55
ICB01
SPAT
NA
20.1
7.1
10
5
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.2
7.1
70
325
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
7.1
134
795
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.1
581
4672
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
7.1
84
424
K29.1
ICD-10 Finland
Other acute gastritis
3.5
7.1
31
90
R06.4
ICD-10 Finland
Hyperventilation
2.9
7.1
39
134
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.2
7.1
67
306
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
7.1
205
1362
DHB50
NOMESCO Finland
Turbinoplasty
2.4
7.0
57
244
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
7.0
117
665
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.7
7.0
46
175
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
7.0
64
287
M54.8
ICD-10 Finland
Other dorsalgia
2.0
7.0
81
404
K60.1
ICD-10 Finland
Chronic anal fissure
2.8
7.0
42
152
J01AA07
ATC
tetracycline; systemic
1.4
7.0
371
2786
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
7.0
138
831
E86
ICD-10 Finland
Volume depletion
3.5
7.0
30
86
K59.9
ICD-10 Finland
Functional intestinal disorder, unspecified
3.6
7.0
29
81
A07AA02
ATC
nystatin; oral
2.1
7.0
77
380
S13
ICPC
Animal/human bite
2.2
7.0
64
290
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
6.9
127
744
R51
ICD-10 Finland
Headache
1.7
6.9
127
746
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
6.9
202
1344
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.1
6.9
74
359
R52.1
ICD-10 Finland
Chronic intractable pain
5.8
6.9
18
31
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.4
6.9
55
232
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
7.5
6.9
15
20
L30.3
ICD-10 Finland
Infective dermatitis
2.3
6.9
59
260
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
13.8
6.9
11
8
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
13.8
6.9
11
8
R32
ICD-10 Finland
Unspecified urinary incontinence
3.1
6.9
35
114
K25
ICPC
Fear of hypertension
2.8
6.9
42
154
C07AB03
ATC
atenolol; systemic
2.5
6.9
49
196
M35.7
ICD-10 Finland
Hypermobility syndrome
2.8
6.9
41
148
I95.1
ICD-10 Finland
Orthostatic hypotension
3.7
6.9
28
77
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
6.9
58
253
LCA06
NOMESCO Finland
Biopsy of endometrium
1.6
6.8
169
1078
R19.4
ICD-10 Finland
Change in bowel habit
2.8
6.8
40
142
R45.2
ICD-10 Finland
Unhappiness
4.8
6.8
21
44
L70.0
ICD-10 Finland
Acne vulgaris
1.7
6.8
133
796
A60
ICPC
General and Unspecified, Result test/procedure
2.0
6.8
78
390
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
6.8
110
623
JGC01
NOMESCO Finland
Laparoscopic rectopexy
6.7
6.8
16
24
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
6.8
98
531
F20.38
ICD-10 Finland
Undifferentiated schizophrenia other definite
11.0
6.8
12
11
RS312
NOMESCO Finland
NA
11.0
6.8
12
11
D16
ICPC
Rectal bleeding
2.5
6.8
49
198
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.9
6.8
39
136
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
2.2
6.8
63
288
-60
ICPC
Result test/procedure
1.8
6.8
102
564
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
5.3
6.8
19
36
RT134
NOMESCO Finland
NA
40.1
6.8
8
*
F40.0
ICD-10 Finland
Agoraphobia
40.1
6.8
8
*
Y87.0
ICD-10 Finland
Sequelae of intentional self-harm
40.1
6.8
8
*
N05AL05
ATC
amisulpride; oral
40.1
6.8
8
*
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.9
6.8
88
462
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
6.7
149
925
F20.31
ICD-10 Finland
Undifferentiated schizophrenia periodically with gradual deterioration
16.7
6.7
10
6
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.5
6.7
191
1265
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
6.7
223
1529
U71
ICPC
Cystitis/urinary infection other
1.8
6.7
116
670
F91.9
ICD-10 Finland
Conduct disorder, unspecified
7.2
6.7
15
21
P02
ICPC
Acute stress reaction
1.7
6.7
123
723
W02
ICPC
Fear of pregnancy
3.2
6.7
32
100
IEY07
NOMESCO Finland
Psychiatric job coaching
22.6
6.7
9
*
R1270
NOMESCO Finland
Evaluation of the need for educational rehabilitation
22.6
6.7
9
*
RS314
NOMESCO Finland
NA
22.6
6.7
9
*
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.6
6.7
47
186
R45.8
ICD-10 Finland
Other symptoms and signs involving emotional state
4.9
6.7
20
41
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
2.6
6.7
44
169
D93
ICPC
Irritable bowel syndrome
3.1
6.6
33
106
SPAT1272
SPAT
Drug screening
5.5
6.6
18
33
IEP02
NOMESCO Finland
Child-centred family therapy
12.3
6.6
11
9
N07BB04
ATC
naltrexone; oral
12.3
6.6
11
9
OAB48
SPAT
NA
0.6
6.6
128
1965
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.2
6.6
61
277
F20.32
ICD-10 Finland
Undifferentiated schizophrenia stable periodically
8.7
6.5
13
15
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
6.5
142
877
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.1
6.5
66
312
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
10.0
6.5
12
12
Z70.9
ICD-10 Finland
Sex counselling, unspecified
10.0
6.5
12
12
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
10.0
6.5
12
12
S06
ICPC
Rash localized
1.8
6.5
109
622
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.7
6.5
42
157
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
6.5
202
1367
J45
ICD-10 Finland
Asthma
1.6
6.5
170
1101
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.5
73
362
H02AB09
ATC
hydrocortisone; systemic
2.5
6.5
49
201
XKC03
NOMESCO Finland
Water cystometry
2.6
6.5
43
166
I84.5
ICD-10 Finland
External hemorrhoids without complication
2.5
6.5
47
191
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
5.3
6.5
18
34
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
5.3
6.5
18
34
-50
ICPC
Medication/prescr/renewal
2.1
6.4
66
316
IEY18
NOMESCO Finland
Psychiatric sleep coaching, individual
70.0
6.4
7
*
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.4
6.4
29
87
S02.51
ICD-10 Finland
Fracture of tooth, open
1.6
6.4
160
1027
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.4
95
523
F34.8
ICD-10 Finland
Other persistent mood [affective] disorders
14.3
6.4
10
7
E970A
ICD-9 Finland
Injury due to legal intervention by firearms
14.3
6.4
10
7
F20.20
ICD-10 Finland
Catatonic schizophrenia continuously
14.3
6.4
10
7
Y90.8
ICD-10 Finland
Blood alcohol level of 240 mg/100 ml or more
14.3
6.4
10
7
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
6.4
693
5772
D95
ICPC
Anal fissure/perianal abscess
3.5
6.4
27
77
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
3.6
6.4
26
72
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
6.4
206
1407
NB6AA
NOMESCO Finland
Humerus X-ray examination
3.3
6.3
29
88
N77.1*B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
2.2
6.3
62
288
IEP03
NOMESCO Finland
Focused parental counselling
8.2
6.3
13
16
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.4
6.3
51
216
D07AB08
ATC
desonide; topical
1.5
6.3
211
1449
F23.00
ICD-10 Finland
Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor
11.0
6.3
11
10
P62
ICPC
Psychological, Administrative procedure
11.0
6.3
11
10
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.7
6.3
258
3457
S80.0
ICD-10 Finland
Contusion of knee
1.7
6.3
133
817
F25
ICD-10 Finland
Schizoaffective disorders
9.3
6.3
12
13
F60.2
ICD-10 Finland
Dissocial personality disorder
9.3
6.3
12
13
F20.33
ICD-10 Finland
Undifferentiated schizophrenia periodically with gradual improvement
9.3
6.3
12
13
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
2.9
6.3
36
125
A10BH01
ATC
sitagliptin; oral
1.9
6.3
84
445
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
4.0
6.3
23
58
M54
ICD-10 Finland
Dorsalgia
1.5
6.3
212
1459
Z72.2
ICD-10 Finland
Drug use
4.6
6.3
20
44
N41.9
ICD-10 Finland
Inflammatory disease of prostate, unspecified
3.8
6.3
24
63
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.6
6.3
138
859
IFC99
NOMESCO Finland
Other biological psychiatric intervention
18.1
6.3
9
5
F93.2
ICD-10 Finland
Social anxiety disorder of childhood
+∞
6.3
6
*
F44.81
ICD-10 Finland
Side person disorder
+∞
6.3
6
*
F45.39
ICD-10 Finland
Somatoform autonomic dysfunction multiple or indeterminate organs
+∞
6.3
6
*
3094A
ICD-9 Finland
Adjustment reaction, With mixed disturbance of emotions and conduct
+∞
6.3
6
*
AA500
NOMESCO Finland
Transcranial magnetic stimulation
+∞
6.3
6
*
S08
ICPC
Skin colour change
2.0
6.2
78
405
IER06
NOMESCO Finland
Rehabilitative psychiatric group intervention, Social Cognition and Interaction Training (SCIT)
26.7
6.2
8
*
N06BA02
ATC
dexamfetamine; oral
26.7
6.2
8
*
F23.01
ICD-10 Finland
Acute polymorphic psychosis without an actual schizophrenic disease picture with an acute stress factor
26.7
6.2
8
*
RT210
NOMESCO Finland
NA
26.7
6.2
8
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
26.7
6.2
8
*
XG466
NOMESCO Finland
Sleep oxymetry
2.6
6.2
44
174
M03BX01
ATC
baclofen; systemic
3.2
6.2
30
95
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.8
6.2
108
625
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
6.2
66
319
JAH01
NOMESCO Finland
Laparoscopy
1.9
6.2
82
435
H92.0
ICD-10 Finland
Otalgia
1.7
6.2
115
678
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
6.2
543
4400
ZXA10
NOMESCO Finland
Bilateral
1.4
6.2
265
1914
R73
ICD-10 Finland
Elevated blood glucose level
3.1
6.2
31
101
XQ800
NOMESCO Finland
Prick test
1.5
6.1
180
1202
WX872
NOMESCO Finland
Intensive care
2.3
6.1
53
234
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
3.1
6.1
30
96
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.1
6.1
61
288
K05.08
ICD-10 Finland
Another acute gingivitis
2.1
6.1
66
323
S74
ICPC
Dermatophytosis
2.7
6.1
40
152
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
6.1
429
3366
F30.9
ICD-10 Finland
Manic episode, unspecified
7.7
6.1
13
17
EBA05
SPAT
NA
3.4
6.1
27
80
Z25
ICPC
Assault/harmful event problem
3.2
6.1
29
91
Z10
ICPC
Health care system problem
12.5
6.1
10
8
IBZ05
NOMESCO Finland
Evaluation of patient with eating disorder
8.6
6.0
12
14
SPA47
NOMESCO Finland
Precision impression for denture
4.4
6.0
20
46
H03
ICPC
Tinnitus, ringing/buzzing ear
2.8
6.0
36
131
F23.9
ICD-10 Finland
Acute and transient psychotic disorder, unspecified
10.0
6.0
11
11
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.0
6.0
31
103
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
3.2
6.0
29
92
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028707) Methadone [Presence] in Urine by Screen method
447
582
8.88
307.65
3.2
2.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1024
3186
4.40
296.24
2.1
1.6
%
1.5
1.3
14.71
932
2885
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1371
5844
3.52
240.93
1.9
1.6
pmol/l
99.3
98.2
0.40
755
3201
(3015377) Calcium [Moles/volume] in Serum or Plasma
1208
5038
3.37
214.90
2.5
2.9
mmol/l
2.4
2.3
2.20
1083
4565
(3019309) Folate [Moles/volume] in Red Blood Cells
695
2042
4.15
209.89
1.7
1.6
nmol/l
1100.5
1195.7
1.94
547
1575
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1380
6545
3.09
192.27
5.9
5.2
mmol/l
1.2
1.2
0.86
1270
5982
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1491
7384
3.07
192.24
6.9
5.7
mmol/l
1.2
1.2
0.64
1288
6257
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
162
107
15.96
186.55
11.7
11.3
mmol/l
0.6
0.6
0.04
152
95
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1384
6697
3.01
184.01
3.9
2.9
u/l
28.8
30.3
0.75
1297
6390
(3011288) Drugs identified in Urine by Screen method
500
1279
4.50
179.86
4.2
2.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
826
3070
3.35
171.86
1.6
1.4
nmol/l
20.0
20.6
0.54
768
2713
(3009466) Valproate [Moles/volume] in Serum or Plasma
204
233
9.33
165.01
6.1
5.2
umol/l
381.6
385.0
0.09
180
202
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2539
17887
4.06
163.56
5.4
3.6
pmol/l
14.1
14.4
12.65
2377
16459
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2209
14388
3.15
160.62
7.6
6.2
u/l
76.0
73.5
1.60
2088
13572
(3018418) pH of Serum or Plasma
967
4199
2.94
150.93
3.4
3.7
ph
7.4
7.4
0.70
143
827
(1001926) Buprenorphine [Presence] in Urine by Screen method
506
1551
3.73
139.87
3.2
1.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1438
8011
2.56
132.93
2.5
2.2
nmol/l
68.8
72.0
4.45
1355
7480
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
155
169
9.63
129.57
1.7
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1909
12271
2.58
128.02
3.8
2.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2704
20951
4.59
127.75
6.8
4.1
mu/l
1.8
2.0
0.95
2584
19761
(3013650) Neutrophils [#/volume] in Blood by Automated count
1875
12144
2.50
120.53
15.2
7.9
e9/l
4.0
3.9
0.58
1635
10697
(3024561) Albumin [Mass/volume] in Serum or Plasma
1247
6765
2.46
118.47
4.8
4.6
g/l
37.5
37.1
1.72
1154
6313
(44816559) Phosphatidylethanol [Mass/volume] in Blood
239
466
5.49
117.35
1.4
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
543
1932
3.22
117.34
3.1
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2720
21516
4.50
116.52
15.8
8.7
mmol/l
139.5
139.5
0.10
2661
20801
(3023103) Potassium [Moles/volume] in Serum or Plasma
2724
21583
4.54
116.10
15.8
8.8
mmol/l
3.9
3.9
4.23
2656
20808
(3000764) Benzodiazepines [Presence] in Urine
565
2129
3.05
110.11
3.1
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1479
8859
2.35
109.82
5.4
5.2
umol/l
9.5
10.7
4.32
1366
8315
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
98
68
14.87
109.49
2.2
2.6
nmol/l
147.3
133.5
0.41
86
55
(3013115) Eosinophils [#/volume] in Blood
1721
11012
2.36
109.27
9.3
5.9
e9/l
0.2
0.2
1.42
1523
9900
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2575
19940
3.34
108.24
4.8
3.0
mmol/l
5.7
5.6
3.90
2438
18633
(3006315) Basophils [#/volume] in Blood
1673
10608
2.34
108.05
7.9
5.7
e9/l
0.0
0.0
0.64
1448
9371
(3027008) Opiates [Presence] in Urine
565
2153
3.01
107.77
3.0
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
565
2155
3.01
107.57
3.1
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1666
10585
2.32
106.51
7.9
5.7
e9/l
0.5
0.5
0.42
1447
9360
(3019198) Lymphocytes [#/volume] in Blood
1724
11155
2.32
104.95
7.9
5.6
e9/l
2.0
2.0
0.17
1528
10066
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1048
5517
2.40
103.41
2.8
2.3
u/l
54.6
56.8
1.03
958
5132
(3009508) Creatinine [Moles/volume] in Urine
951
4795
2.45
103.35
3.5
3.3
mmol/l
8.4
8.6
0.47
820
4218
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2227
16247
2.53
100.61
4.2
2.6
u/l
40.8
35.6
2.01
2102
15567
(3013707) Erythrocyte sedimentation rate by Westergren method
2128
15254
2.43
99.25
4.1
3.4
mm/h
9.3
8.7
1.56
1985
14282
(3027944) Amphetamines [Presence] in Urine
543
2133
2.90
97.26
3.1
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
842
4130
2.46
96.14
2.6
1.9
u/l
250.8
273.9
0.16
800
3925
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
899
4588
2.38
93.53
2.5
2.1
mg/l
2.7
2.7
0.24
770
3949
(3019150) Specific gravity of Urine by Refractometry
903
4647
2.36
91.90
4.1
3.1
kg/l
1.0
1.0
0.27
83
750
(42870588) Differential panel, method unspecified - Blood
1155
6684
2.20
87.76
6.8
6.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
466
1820
2.85
83.51
1.9
2.0
nmol/l
395.7
381.6
0.70
419
1690
(3022096) Basophils/100 leukocytes in Blood
1488
9627
2.10
83.33
7.8
5.9
%
0.6
0.7
1.16
1387
9063
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
547
2324
2.66
83.25
2.5
2.6
mmol/l
2.4
2.4
0.07
474
2043
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
658
3086
2.46
81.20
1.7
1.5
pmol/l
453.7
38427721.1
3.03
566
2696
(3006504) Eosinophils/100 leukocytes in Blood
1522
10015
2.08
80.45
7.8
5.7
%
2.6
2.8
3.74
1423
9409
(3019069) Monocytes/100 leukocytes in Blood
1526
10094
2.06
79.02
8.2
6.0
%
8.1
8.1
0.36
1433
9562
(3018010) Neutrophils/100 leukocytes in Blood
1556
10515
2.02
74.23
7.7
5.5
%
56.1
56.0
0.21
1461
9962
(3002030) Lymphocytes/100 leukocytes in Blood
1573
10673
2.02
74.16
7.8
5.6
%
29.9
30.0
0.24
1472
10087
(3013826) Glucose [Moles/volume] in Serum or Plasma
1596
10890
2.02
73.99
5.6
3.9
mmol/l
6.2
6.3
0.63
1466
9668
(40758558) Short blood count panel - Blood
881
4860
2.16
72.90
9.7
6.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2279
17778
2.25
72.73
5.2
3.8
mmol/mol
37.1
37.4
0.67
2130
16880
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1076
6414
2.07
72.43
1.5
1.3
u/ml
1.3
1.5
0.22
263
1793
(3015736) pH of Urine
1307
8422
1.99
70.13
3.9
2.7
—
5.8
—
0
5
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1674
11865
1.95
66.72
3.4
2.7
ug/l
68.4
75.5
1.70
1568
11250
(3048689) Calprotectin [Mass/mass] in Stool
688
3560
2.22
65.98
2.5
2.7
ug/g
80.9
117.5
4.68
527
2860
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2802
24445
4.07
65.58
11.7
7.4
u/l
27.5
26.4
1.82
2732
23693
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
60
44
13.90
64.81
1.9
2.4
umol/l
13.9
15.2
0.34
60
44
(4198724)
97
139
7.18
64.49
2.6
3.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
920
5466
1.99
60.21
1.4
1.4
g/l
2.0
2.1
1.76
510
3589
(3012095) Magnesium [Moles/volume] in Serum or Plasma
491
2285
2.38
60.03
3.5
3.6
mmol/l
0.8
0.8
0.02
446
2146
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
388
1632
2.59
58.97
2.5
2.4
u/l
29.1
39.4
2.50
339
1400
(3003458) Phosphate [Moles/volume] in Serum or Plasma
423
1870
2.47
57.81
5.9
6.0
mmol/l
1.1
1.1
0.34
399
1778
(3031040) Bacteria [#/volume] in Urine by Automated count
1912
14589
1.89
56.29
5.3
3.4
e6/l
102.7
1564.2
1.65
40
152
(3018095) Leukocytes [#/volume] in Urine
1080
6905
1.89
55.92
4.0
3.0
e6/l
62.5
70.1
0.13
725
4406
(3002582) Erythrocytes [#/volume] in Urine
895
5408
1.94
54.81
3.5
2.6
e6/l
30.5
95.0
1.58
668
3980
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2434
20277
2.16
54.08
12.0
7.6
ml/min/173m2
98.9
96.4
6.60
1921
15985
(3030467) Casts [#/volume] in Urine by Automated count
825
4874
1.96
53.83
3.4
2.6
e6/l
0.3
0.3
0.01
599
3514
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
63
68
9.45
52.83
4.6
1.8
umol/l
158.5
187.4
0.18
28
38
(3021447) Carbon dioxide [Partial pressure] in Venous blood
307
1219
2.70
52.15
6.2
3.9
kpa
6.0
5.8
1.78
296
1184
(36304419) Bacteria [Presence] in Urine
828
4942
1.94
52.15
3.3
2.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
658
3625
2.05
52.12
2.8
2.2
e6/l
8.5
7.9
0.41
562
3158
(3024354) Oxygen [Partial pressure] in Venous blood
271
1010
2.85
51.96
5.1
3.4
kpa
4.7
4.7
0.11
260
977
(3026782) Osmolality of Urine
619
3356
2.07
51.11
2.8
2.4
mosm/kgh2o
526.5
568.3
3.66
522
2863
(3033658) Prothrombin time (PT) actual/Normal
763
4456
1.96
51.08
4.1
3.6
%
97.3
94.8
2.46
745
4337
(36660697) Celiac disease serology panel - Serum
456
2195
2.28
50.95
1.3
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1384
9752
1.79
50.83
10.1
7.7
e9/l
0.0
0.0
0.78
1107
8021
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
429
2016
2.32
50.72
2.3
2.8
umol/l
6.3
6.9
0.33
352
1741
(3002032) Base excess in Venous blood by calculation
302
1215
2.66
49.91
6.2
3.9
mmol/l
1.9
1.8
0.18
262
972
(3021387) Prolactin [Units/volume] in Serum or Plasma
401
1847
2.36
49.59
1.9
1.6
mu/l
442.2
284.7
7.56
360
1661
(3014576) Chloride [Moles/volume] in Serum or Plasma
351
1568
2.41
46.37
8.6
6.8
mmol/l
104.5
104.8
0.49
341
1532
(3022948) Iron [Moles/volume] in Serum or Plasma
489
2540
2.11
44.73
2.4
2.2
umol/l
14.2
14.8
0.88
451
2373
(3037467) Urinalysis macro (dipstick) panel - Urine
1940
15423
1.76
43.81
5.0
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2675
23664
2.44
43.28
14.4
8.9
mg/l
19.4
20.8
1.38
2040
17733
(3004789) Transferrin [Mass/volume] in Serum or Plasma
451
2304
2.13
42.96
2.4
2.1
g/l
2.5
2.5
1.92
398
2143
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
748
4556
1.86
42.95
1.6
1.6
mmol/l
1.5
1.3
4.73
656
4006
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
462
2392
2.10
42.46
1.9
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
276
1155
2.53
41.85
10.6
8.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
329
1493
2.36
41.77
2.6
3.6
pmol/l
4.5
4.7
3.36
287
1360
(3014111) Lactate [Moles/volume] in Serum or Plasma
272
1134
2.54
41.57
8.8
7.0
mmol/l
1.3
1.4
0.09
261
1086
(40768797) Stomach Pathology biopsy report
429
2182
2.13
41.22
1.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
332
1544
2.30
39.74
1.7
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
843
5433
1.77
39.64
3.2
2.2
—
—
—
0
0
(3013512) EKG study
652
3888
1.87
39.60
3.3
2.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
1013
6887
1.72
39.34
2.7
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2473
21414
1.97
39.27
4.5
3.3
mmol/l
2.8
2.8
0.07
2313
20270
(3023511) Choriogonadotropin [Units/volume] in Urine
294
1307
2.39
39.02
1.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
510
2821
1.98
38.78
2.9
2.3
e6/l
1.4
1.2
0.35
258
1493
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
302
1364
2.35
38.65
3.2
2.6
g/l
0.2
0.2
0.31
282
1286
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
201
748
2.81
38.43
6.4
4.2
mmol/l
24.5
24.2
0.81
184
696
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
325
1519
2.28
38.40
1.7
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2457
21303
1.93
37.79
4.2
3.1
mmol/l
4.6
4.7
2.27
2320
20315
(3017143) Hepatitis C virus Ab [Presence] in Serum
705
4381
1.80
37.15
2.0
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2409
20835
1.86
36.22
21.0
10.8
%
13.4
13.3
1.08
2373
20390
(3007853) Bacteria identified in Skin by Aerobe culture
424
2252
2.03
35.97
1.9
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
484
2693
1.95
35.96
3.1
2.8
ng/l
100.0
559.0
5.28
257
1523
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
826
5431
1.72
35.50
3.1
2.5
ng/l
24.0
34.8
1.16
390
2480
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2433
21182
1.86
34.79
4.1
3.1
mmol/l
1.4
1.5
11.85
2272
20149
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1076
7626
1.65
34.60
2.9
2.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
35
30
11.80
34.30
7.5
10.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
478
2693
1.93
34.08
3.0
2.4
e6/l
4.1
3.8
0.22
231
1367
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
395
2087
2.03
33.88
2.5
2.2
%
22.8
24.6
1.62
338
1813
(3000494) Fungus identified in Specimen by Culture
406
2177
2.00
33.39
1.6
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
343
1733
2.11
33.16
6.8
4.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
184
708
2.71
32.95
5.2
3.0
g/l
131.4
132.5
0.28
179
697
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
155
546
2.94
32.75
5.4
2.7
%
0.6
0.7
0.84
148
532
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
399
2145
2.00
32.53
1.2
1.2
iu/ml
98.4
149.3
1.83
127
841
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
345
1763
2.08
32.33
1.1
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
243
1079
2.36
32.18
1.1
1.1
u/ml
1.4
4.0
—
5
13
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
605
3759
1.77
31.21
2.5
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
338
1742
2.06
30.90
2.2
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
729
4783
1.70
30.88
3.9
2.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
252
1172
2.26
29.91
8.8
8.0
%
96.2
96.4
0.25
246
1128
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
715
4714
1.68
29.55
2.8
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
608
3838
1.74
29.48
4.5
3.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2331
20329
1.71
29.46
3.8
2.9
mmol/l
1.3
1.2
11.76
2173
19336
(3003396) Base excess in Arterial blood by calculation
274
1327
2.17
29.43
8.6
7.5
mmol/l
1.3
0.7
1.51
213
990
(3042517) Benzodiazepines panel - Urine
31
28
11.18
29.35
2.7
2.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
271
1329
2.14
28.16
8.6
7.5
kpa
12.6
13.7
2.19
261
1272
(3000570) Elastase.pancreatic [Mass/mass] in Stool
118
388
3.13
28.12
1.4
1.3
ug/g
300.8
307.7
0.12
55
204
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
270
1329
2.14
27.78
8.6
7.5
kpa
5.1
5.0
0.91
262
1267
(3024928) Oxygen saturation in Venous blood
95
278
3.50
27.30
6.1
3.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
684
4543
1.66
27.16
1.9
1.8
mg/l
0.9
1.0
0.26
459
3234
(3027945) Reticulocytes/100 erythrocytes in Blood
284
1442
2.07
26.91
3.7
3.0
%
1.6
1.7
0.34
243
1302
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
232
1096
2.21
26.45
2.0
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
62
138
4.57
25.94
2.5
1.7
mosm/kgh2o
284.4
285.6
0.16
48
109
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
462
2794
1.78
25.70
2.4
2.8
ng/l
923.6
824.4
0.09
354
2261
(3013139) Helicobacter pylori Ag [Presence] in Stool
256
1300
2.06
24.19
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
190
858
2.30
24.12
3.2
3.4
mmol/l
1.1
1.3
0.26
127
617
(3023183) Ammonium ion [Moles/volume] in Plasma
91
282
3.30
23.94
2.3
3.1
umol/l
33.0
33.8
0.13
79
244
(21494755) Public health laboratory ask at order entry panel
209
4068
0.48
23.87
1.3
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
67
169
4.03
23.87
2.4
1.3
promille
1.3
1.3
0.03
52
133
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
169
730
2.40
23.75
1.7
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
195
899
2.25
23.56
3.3
3.3
kpa
5.2
5.1
0.39
182
845
(3008152) Bicarbonate [Moles/volume] in Arterial blood
166
715
2.40
23.47
7.0
6.5
mmol/l
24.6
24.0
1.08
158
660
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
150
618
2.50
23.36
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
150
622
2.49
23.04
1.2
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
116
423
2.81
23.03
2.2
2.3
ug/l
275.9
390.2
0.45
105
386
(3052851) Hemolysis interference index of Serum or Plasma
125
476
2.70
22.85
3.4
2.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1391
11134
1.47
22.81
4.0
2.9
estimate
0.0
0.0
1.08
238
2207
(42529406) Shigella sp [Presence] in Stool by Culture
150
625
2.48
22.81
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
403
2421
1.77
22.76
2.2
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
388
2311
1.78
22.56
2.5
2.3
s
29.3
29.5
0.28
381
2235
(3009261) Glucose [Presence] in Urine by Test strip
1400
11241
1.47
22.47
4.0
3.0
estimate
0.0
0.0
1.06
255
2215
(3009343) pH of Capillary blood
191
891
2.22
22.43
3.3
3.3
ph
7.4
7.4
0.13
27
108
(3032080) INR in Blood by Coagulation assay
795
5696
1.54
22.25
6.0
5.5
inr
1.1
1.1
0.71
257
1948
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
134
538
2.56
22.03
1.6
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2721
25319
1.99
21.71
14.1
8.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1385
11165
1.45
21.38
5.2
4.1
estimate
0.0
0.0
0.42
255
2294
(3016650) Hepatitis A virus Ab [Presence] in Serum
110
406
2.78
21.36
1.2
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
162
720
2.32
21.34
1.4
1.5
—
—
—
0
0
(3019225) pH of Specimen
248
1302
1.99
21.32
4.6
3.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
203
994
2.12
21.09
1.6
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2879
27486
3.22
20.62
26.3
13.0
e9/l
264.7
259.5
4.62
2818
26816
(3017446) Testosterone [Moles/volume] in Serum or Plasma
299
1692
1.85
20.49
2.7
2.0
nmol/l
10.9
12.1
1.47
272
1548
(3003327) Ova and parasites identified in Stool by Light microscopy
189
913
2.14
20.33
1.7
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
159
716
2.29
20.32
5.0
4.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
475
3072
1.65
20.31
1.5
1.4
titre
441.4
581.5
0.84
84
604
(3024731) MCV [Entitic volume]
2880
27530
3.19
20.00
26.1
13.0
fl
89.5
89.4
0.27
2848
27192
(3035941) MCH [Entitic mass]
2880
27530
3.19
20.00
26.1
12.9
pg
29.9
29.9
0.47
2848
27192
(3023520) Reticulocytes [#/volume] in Blood
197
974
2.10
19.95
3.0
2.9
e9/l
66.4
70.3
0.88
135
706
(3026361) Erythrocytes [#/volume] in Blood
2880
27536
3.18
19.88
26.3
13.0
e12/l
4.6
4.6
0.25
2817
26824
(3010813) Leukocytes [#/volume] in Blood
2881
27552
3.20
19.85
26.5
13.0
e9/l
6.7
6.8
0.30
2812
26823
(3000963) Hemoglobin [Mass/volume] in Blood
2881
27552
3.20
19.85
26.4
13.1
g/l
136.2
136.7
1.18
2849
27206
(3003181) Sodium [Moles/volume] in Urine
57
147
3.93
19.74
1.8
1.4
mmol/l
61.7
72.4
0.62
41
130
(3022145) Colonoscopy Study observation
335
1994
1.77
19.39
1.3
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
237
1266
1.95
19.35
3.6
3.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
763
5598
1.49
18.50
5.5
3.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
100
379
2.70
18.49
1.1
1.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
158
739
2.20
18.44
10.9
9.5
%
1.6
1.3
1.82
158
733
(3020779) Urea [Moles/volume] in Serum or Plasma
226
1209
1.94
18.36
7.8
7.8
mmol/l
6.8
7.4
0.80
216
1166
(3012516) Albumin [Mass/volume] in Urine
533
3638
1.57
18.05
3.5
3.5
mg/l
621.6
253.6
0.77
350
2502
(3015235) Bicarbonate [Moles/volume] in Capillary blood
88
321
2.80
17.52
2.5
2.2
mmol/l
24.3
24.3
0.00
82
282
(3014007) Fractional oxyhemoglobin in Arterial blood
155
739
2.16
17.25
11.2
9.7
%
93.3
94.6
1.29
155
734
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
176
885
2.05
17.04
1.8
2.0
ug/l
4.8
7.2
1.91
149
785
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
154
741
2.14
16.74
11.2
9.5
%
0.7
0.7
0.10
154
736
(3029937) Albumin [Presence] in Urine by Test strip
790
5945
1.45
16.50
4.5
3.1
estimate
0.0
0.0
1.94
244
2231
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
185
960
1.99
16.41
4.1
4.2
ng/l
83.2
74.3
0.61
166
879
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
171
874
2.02
15.83
1.5
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
425
2832
1.59
15.81
1.6
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
269
1593
1.76
15.76
2.1
2.5
g/l
10.3
10.6
0.69
238
1471
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
525
3672
1.52
15.72
1.3
1.2
iu/ml
14.4
22.6
4.03
131
1111
(3020630) Protein [Mass/volume] in Serum or Plasma
165
835
2.03
15.70
1.7
2.5
g/l
66.6
68.1
1.69
146
784
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
53
153
3.51
15.66
1.8
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
405
2679
1.59
15.53
2.7
2.3
u/l
6999.2
6948.4
0.01
125
1164
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
206
1132
1.88
15.42
2.4
3.2
mmol/l
1.2
1.2
0.54
173
975
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
216
1217
1.84
14.94
1.4
1.4
—
—
—
0
0
(3020891) Body temperature
103
441
2.38
14.83
6.5
4.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
136
658
2.12
14.60
10.6
9.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
231
1339
1.79
14.55
10.7
13.7
inr
1.1
1.2
0.53
35
229
(3026389) Candida sp identified in Specimen by Organism specific culture
82
319
2.62
14.46
1.6
1.2
—
—
—
0
0
(4010399)
203
1138
1.84
14.27
1.4
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
489
3439
1.51
14.14
1.3
1.2
u/ml
2.5
10.9
10.16
159
1464
(3009214) Lutropin [Units/volume] in Serum or Plasma
229
1337
1.77
14.08
1.5
1.4
u/l
7.3
7.7
0.24
181
1096
(3021901) Oxygen saturation in Capillary blood
61
206
3.00
14.02
2.0
2.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
127
609
2.13
13.97
1.3
1.4
titre
105.4
81.4
0.37
13
63
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
183
3172
0.55
13.89
1.6
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
43
117
3.71
13.89
2.6
3.7
%
11.1
11.2
0.04
43
117
(3020682) Albumin/Creatinine [Ratio] in Urine
531
3820
1.48
13.70
4.2
4.3
mg/mmol
5.1
11.2
4.82
353
2635
(3020961) Endomysium IgA Ab [Titer] in Serum
247
1490
1.72
13.53
1.2
1.1
titre
38.3
212.0
—
6
40
(3004809) Band form neutrophils/100 leukocytes in Blood
61
211
2.93
13.45
2.9
3.0
%
1.1
1.1
0.00
48
175
(3025941) Bacteria identified in Stool by Culture
242
1456
1.72
13.38
1.3
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
154
814
1.94
12.98
1.2
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
128
639
2.05
12.68
2.4
2.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
91
403
2.30
12.19
1.8
2.0
ug/l
1.6
2.2
0.24
86
357
(3017181) Myelocytes/100 leukocytes in Blood
245
1519
1.67
12.11
5.4
4.3
%
0.8
0.8
0.01
80
370
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
32
78
4.14
12.04
1.2
1.4
pmol/l
13.2
15.3
0.77
26
66
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
108
516
2.13
12.03
1.3
1.3
u/l
13.2
15.7
0.49
83
450
(46235355) HIV 1 and 2 tests - Meaningful Use set
1165
9751
1.32
11.72
2.8
2.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
79
337
2.38
11.54
4.6
3.9
mmol/l
3.7
3.8
2.51
73
314
(3003338) MCHC [Mass/volume]
2395
22259
1.41
11.45
23.3
10.8
g/l
333.6
333.9
0.88
2385
22065
(3022313) Gas panel - Capillary blood
126
652
1.97
11.33
4.0
3.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
233
1466
1.64
10.88
5.5
4.3
%
0.1
0.1
0.93
74
348
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
51
181
2.85
10.80
1.1
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
119
614
1.98
10.80
12.3
10.2
mmol/l
24.4
24.1
0.60
106
587
(3015171) Extractable nuclear Ab [Units/volume] in Serum
155
878
1.81
10.58
1.3
1.2
u/ml
0.2
0.9
—
7
68
(40767503) Oxygen content in Capillary blood by calculation
66
272
2.46
10.43
2.1
2.1
%
17.7
17.3
0.28
36
132
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1060
8867
1.31
10.34
4.1
2.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
69
294
2.38
10.15
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
69
294
2.38
10.15
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
77
345
2.26
10.10
1.6
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
97
477
2.07
10.07
1.1
1.3
mmol/l
3.7
3.6
0.35
89
447
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
63
259
2.46
10.02
1.7
2.4
nmol/l
22.1
22.5
0.10
58
250
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
54
207
2.64
9.91
1.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
83
387
2.18
9.89
1.6
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
220
1400
1.62
9.82
5.0
4.1
%
0.7
0.5
0.30
54
288
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
105
537
1.99
9.80
2.2
1.7
pmol/l
179.1
199.8
0.89
100
514
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
106
547
1.97
9.65
1.2
1.4
mg/l
368.1
466.4
2.74
100
520
(3028026) IgM [Mass/volume] in Serum or Plasma
195
1212
1.65
9.57
1.7
1.7
g/l
1.4
1.3
0.12
174
1134
(3008757) Leukocyte morphology finding [Identifier] in Blood
44
155
2.87
9.48
3.5
3.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
113
602
1.91
9.38
3.9
3.8
mmol/l
24.2
24.5
0.75
108
577
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
15
23
6.55
9.35
1.3
1.0
—
—
—
0
0
(3010421) pH of Blood
79
374
2.14
9.09
2.8
3.4
ph
7.4
7.4
0.56
67
322
(1761868) Lipid panel - Serum or Plasma
760
9216
0.76
9.06
2.5
2.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
131
2214
0.57
8.95
1.4
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
218
1416
1.58
8.95
5.6
4.4
%
0.0
0.4
0.63
63
309
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
12
5
24.08
8.90
1.2
1.6
nmol/l
591.9
897.9
—
12
5
(3004588) Protein electrophoresis panel - Serum or Plasma
117
645
1.85
8.77
1.7
2.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
140
816
1.75
8.72
2.7
2.6
ng/l
100.0
128.4
0.40
126
705
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
94
483
1.98
8.70
1.2
1.5
e6/l
3.2
18.5
4.18
72
384
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
94
483
1.98
8.70
1.3
1.5
e6/l
648.0
1405.7
0.42
76
399
(3017732) Neutrophils [#/volume] in Blood
224
1477
1.56
8.62
5.6
2.1
e9/l
4.3
4.1
0.43
173
1260
(43055514) Macroprolactin [Presence] in Serum or Plasma
39
136
2.89
8.59
1.2
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
304
4215
0.69
8.52
1.4
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
147
875
1.72
8.51
2.0
1.6
nmol/l
36.9
39.5
0.67
147
866
(3044290) Cell count panel - Cerebral spinal fluid
88
448
1.99
8.37
1.2
1.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
46
178
2.61
8.34
1.2
1.6
umol/l
10.1
10.9
0.48
41
171
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
79
388
2.06
8.29
1.3
1.2
—
10.8
—
0
5
(3006653) Thiamine [Moles/volume] in Blood
26
72
3.63
8.28
1.4
1.4
nmol/l
144.0
143.4
0.02
26
72
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
22
54
4.10
8.25
1.3
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
265
1844
1.48
7.92
1.5
1.4
iu/l
15.7
18.3
0.99
220
1539
(1002224) Polysomnography panel
161
1003
1.64
7.87
1.1
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
33
111
3.00
7.77
1.5
1.5
nmol/l
1.7
3.8
0.58
27
90
(3025468) Yersinia sp identified in Specimen by Organism specific culture
51
215
2.40
7.76
1.6
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
78
392
2.02
7.72
1.3
1.3
u/ml
1.2
1.2
—
5
31
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
101
3.09
7.70
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
51
216
2.39
7.69
1.6
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
44
174
2.55
7.66
1.3
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
53
229
2.34
7.64
1.8
1.6
mu/l
107.7
58.9
0.53
43
205
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
17
36
4.74
7.63
2.6
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
17
36
4.74
7.63
2.6
2.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
68
326
2.11
7.63
2.7
3.4
mmol/l
2.5
2.0
0.48
45
190
(3017354) Segmented neutrophils/100 leukocytes in Blood
35
123
2.87
7.63
3.5
2.6
%
58.6
55.2
0.39
23
87
(3005988) Vibrio sp identified in Specimen by Organism specific culture
51
217
2.37
7.61
1.6
1.3
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
10
12
8.36
7.58
1.3
1.8
nmol/l
56.4
12.7
—
10
12
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
44
175
2.54
7.58
1.3
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
51
218
2.36
7.54
1.7
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
51
219
2.35
7.46
1.7
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
232
1594
1.49
7.39
4.0
2.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
125
742
1.72
7.35
1.6
1.5
nmol/l
0.5
0.5
0.02
104
624
(40768804) Tissue Pathology biopsy report
948
8082
1.26
7.32
2.0
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
38
144
2.66
7.22
4.4
3.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
51
224
2.30
7.11
1.7
1.3
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
21
56
3.77
7.07
3.9
2.9
umol/l
27.1
29.8
0.48
15
46
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
211
1436
1.51
7.05
2.4
2.3
au/ml
26.2
18.1
—
7
133
(3035637) Corticotropin [Mass/volume] in Plasma
54
244
2.24
7.05
1.5
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
269
1921
1.44
7.04
3.7
3.1
%
31.1
32.1
0.73
204
1436
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
139
864
1.64
6.89
1.1
1.1
u/ml
4.0
4.5
0.10
11
151
(3016018) Differential panel - Cerebral spinal fluid
50
221
2.28
6.88
1.2
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
115
681
1.72
6.84
1.6
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
928
7944
1.25
6.80
2.0
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
123
1963
0.61
6.72
1.7
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
50
225
2.24
6.61
1.3
1.9
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
35
134
2.63
6.55
1.2
1.2
u/l
41.3
61.5
2.09
24
84
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
63
315
2.02
6.39
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
65
329
2.00
6.37
2.5
2.8
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
91
516
1.79
6.32
1.4
1.3
u/ml
3.6
13.1
1.43
12
80
(3040151) Glucose [Moles/volume] in Capillary blood
43
185
2.34
6.32
9.2
3.7
mmol/l
6.4
6.6
0.28
35
152
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
90
509
1.79
6.30
1.3
1.3
u/ml
4.0
4.7
—
10
53
(3005322) IgE [Units/volume] in Serum or Plasma
242
1733
1.43
6.25
1.2
1.2
u/ml
172.2
239.1
1.20
222
1600
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
54
260
2.10
6.07
1.2
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
83
465
1.81
6.01
1.3
1.2
u/ml
30.9
37.6
—
7
41
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
106
639
1.68
5.95
2.0
2.2
iu/l
3.0
4.6
2.21
39
277
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
48
223
2.17
5.91
1.6
1.5
pmol/l
539.5
337.0
0.99
39
179
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
101
2.79
5.89
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
396
4991
0.76
5.89
1.5
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
68
360
1.91
5.89
1.7
2.2
g/l
137.8
132.8
1.00
53
278
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
222
1587
1.43
5.80
4.3
4.1
u/l
221.1
239.6
1.47
209
1510
(3032057) Clostridioides difficile [Presence] in Stool
12
24
5.02
5.74
2.3
2.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
54
267
2.04
5.68
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
169
2.33
5.67
1.3
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
173
1189
1.48
5.56
1.6
1.6
mg/l
3.3
4.0
0.38
140
747
(3009542) Hematocrit [Volume Fraction] of Blood
2490
23860
1.28
5.53
19.6
9.4
%
40.2
40.5
1.56
1888
20031
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
411
3264
1.30
5.49
3.4
3.6
ug/l
1.4
1.8
1.58
360
3008
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
192
2.20
5.41
1.2
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
57
293
1.96
5.40
2.3
2.2
g/l
0.4
0.6
0.30
48
272
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
110
1710
0.63
5.40
1.6
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
113
712
1.61
5.38
2.5
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
26
95
2.75
5.36
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
37
161
2.31
5.35
1.1
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
105
652
1.63
5.30
2.3
2.0
g/l
0.2
0.2
1.42
98
624
(3044640) Blood type and Crossmatch panel - Blood
760
6525
1.22
5.17
2.4
2.0
—
—
—
0
0
(3036489) Thrombin time
126
826
1.55
5.08
2.1
2.4
s
21.1
21.1
0.01
103
703
(3004716) Salmonella sp identified in Stool by Organism specific culture
253
1896
1.37
5.04
1.4
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
9
9
10.03
5.02
1.9
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
141
2048
0.67
5.02
1.5
1.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
53
274
1.95
4.97
2.0
2.1
g/l
0.0
0.0
0.63
46
261
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
895
7834
1.20
4.96
2.0
1.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
106
672
1.60
4.94
2.3
2.0
g/l
1.1
1.2
1.40
100
644
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
112
721
1.58
4.90
3.2
2.9
g/l
3.6
3.6
0.02
106
683
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
112
2.51
4.87
2.8
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
112
2.51
4.87
2.8
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
112
2.51
4.87
2.8
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
333
1.85
4.87
2.1
2.1
g/l
3.0
3.1
0.18
47
279
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
121
796
1.54
4.82
1.9
2.0
u/l
41.6
38.7
1.03
115
747
(40768443) Skin Pathology biopsy report
115
748
1.56
4.82
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
42
202
2.09
4.80
2.5
2.4
e9/l
1.3
1.2
0.35
19
113
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
67
379
1.79
4.78
2.0
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
39
183
2.15
4.75
1.2
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
52
3.28
4.74
3.6
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
52
3.28
4.74
3.6
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
34
151
2.27
4.73
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
206
2764
0.73
4.68
1.5
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
19
63
3.03
4.67
3.1
3.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
353
1.80
4.64
2.1
2.0
g/l
7.0
7.2
0.46
48
284
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
353
1.80
4.64
2.1
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
63
353
1.80
4.64
2.1
2.0
g/l
3.6
3.8
0.62
47
268
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
53
3.22
4.61
3.7
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
34
153
2.24
4.59
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
49
254
1.94
4.59
1.9
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
203
1493
1.39
4.56
1.3
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
48
248
1.95
4.54
1.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
49
255
1.94
4.54
2.1
2.2
g/l
0.0
0.0
0.00
42
244
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
92
577
1.61
4.52
1.6
1.8
—
194.4
—
0
25
(3020717) Zinc [Moles/volume] in Serum or Plasma
30
129
2.34
4.50
2.0
1.5
umol/l
32.7
26.2
0.46
30
122
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
49
256
1.93
4.49
2.1
2.2
g/l
0.0
0.0
0.00
42
244
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
23
87
2.66
4.48
1.7
2.8
ug/l
1.4
1.1
0.28
23
79
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
38
182
2.10
4.42
2.5
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
108
710
1.54
4.35
2.5
2.8
%
152.4
166.8
1.22
96
682
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
94
599
1.59
4.34
1.6
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
67
392
1.73
4.29
1.3
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
42
212
2.00
4.26
1.2
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
47
247
1.92
4.25
2.2
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
59
334
1.78
4.24
2.9
2.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
51
277
1.86
4.18
2.0
2.1
g/l
38.6
38.7
0.04
46
251
(3049717) Cytology report of Urine Cyto stain
58
329
1.78
4.14
2.2
2.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
70
420
1.68
4.11
2.8
3.8
u/ml
88365.9
678.2
0.49
59
367
(3052592) Norovirus Ag [Presence] in Stool
10
23
4.36
4.09
1.1
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
20
74
2.71
4.08
1.2
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
331
1.77
4.07
2.1
2.1
g/l
10.0
10.8
0.71
49
296
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
26
110
2.38
4.06
1.5
1.3
u/l
6.0
6.6
0.25
21
86
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
64
376
1.72
4.06
2.0
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
19
69
2.77
4.01
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
43
225
1.92
3.96
1.4
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
87
2.54
3.96
1.4
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
70
2.73
3.92
3.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
70
2.73
3.92
3.5
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
70
2.73
3.92
3.5
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
70
2.73
3.92
3.5
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
35
171
2.06
3.90
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
35
171
2.06
3.90
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
35
172
2.05
3.85
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
35
172
2.05
3.85
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
35
172
2.05
3.85
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
35
172
2.05
3.85
1.2
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
88
570
1.56
3.83
1.4
1.4
u/ml
103.2
103.6
0.01
16
114
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
47
257
1.84
3.81
1.3
1.1
mg/l
31.4
42.7
2.02
41
207
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
129
907
1.44
3.79
1.1
1.1
u/ml
2.7
1.7
0.64
62
403
(40760888) Immunoglobulin light chains.free panel - Serum
36
180
2.01
3.78
2.1
3.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
105
710
1.50
3.76
1.3
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
71
439
1.63
3.75
2.7
2.6
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
8
12
6.68
3.67
17.8
3.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
32
155
2.08
3.66
2.8
1.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
33
162
2.05
3.65
2.0
2.9
%
99.4
96.2
0.25
28
154
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
23
97
2.38
3.64
1.1
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
31
149
2.09
3.62
1.7
2.1
pg
32.0
32.7
0.31
31
149
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
31
149
2.09
3.62
1.1
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
32
156
2.06
3.61
2.4
2.6
e9/l
0.2
0.2
1.74
25
130
(3008401) Mugwort IgE Ab [Units/volume] in Serum
112
775
1.46
3.59
1.1
1.1
u/ml
0.6
1.5
1.83
57
354
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
317
2572
1.26
3.59
3.6
3.2
%
22.1
21.3
0.35
86
917
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
567
4887
1.20
3.58
2.3
1.9
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
19
74
2.58
3.55
1.2
1.1
%
93.3
91.6
0.12
19
74
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
111
769
1.46
3.54
2.2
2.5
%
94.4
93.8
0.09
103
706
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
9
17
5.31
3.51
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
175
2300
0.75
3.50
1.4
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
96
648
1.50
3.49
2.1
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
17
63
2.71
3.49
1.7
3.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
100
681
1.48
3.48
1.3
1.3
u/ml
261.7
235.5
0.34
55
424
(3051651) Icteric interference index of Serum or Plasma
25
112
2.24
3.48
5.4
3.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
27
125
2.17
3.47
1.3
1.3
—
23.9
—
0
7
(4034850)
88
584
1.52
3.47
9.1
6.3
—
—
—
0
0
(4027681)
40
215
1.87
3.45
1.2
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
115
811
1.44
3.36
1.1
1.1
u/ml
4.7
7.0
0.97
73
463
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
67
421
1.61
3.35
5.7
5.7
iu/ml
5493.4
511.7
—
5
50
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
27
127
2.14
3.35
1.3
1.3
—
64.9
—
0
11
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
397
3330
1.22
3.32
2.0
2.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
48
2.93
3.30
1.1
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
86
575
1.51
3.29
1.9
2.1
g/l
1.4
1.3
0.70
76
506
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
32
162
1.99
3.29
2.4
2.5
e6/l
481.4
531.4
0.24
25
131
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
41
227
1.82
3.24
1.2
1.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
42
235
1.80
3.21
2.5
3.5
mg/l
23.1
30.3
1.49
29
186
(3034860) Kappa light chains.free [Mass/volume] in Serum
42
235
1.80
3.21
2.5
3.5
mg/l
30.9
74.5
0.91
28
185
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
14
49
2.87
3.19
1.2
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
160
1205
1.35
3.18
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
206
1611
1.30
3.15
1.5
1.3
miu/ml
210.5
232.8
0.38
84
819
(3024980) IgG subclass 4 [Mass/volume] in Serum
57
350
1.64
3.15
1.5
1.8
g/l
0.6
0.8
1.60
44
263
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
32
166
1.94
3.09
1.1
1.2
mmol/l
1.7
1.8
0.58
27
155
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
39
3.09
3.09
1.2
1.2
—
—
—
0
0
(44813793)
39
217
1.81
3.05
1.1
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
16
5.01
3.05
1.0
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
33
174
1.91
3.04
1.1
1.1
u/l
1.0
1.0
0.03
14
66
(4268621)
48
285
1.70
3.02
2.5
2.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
73
1084
0.67
3.01
1.3
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
21
4.30
2.99
2.0
2.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
40
3.01
2.97
1.8
2.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
65
419
1.56
2.96
1.3
1.3
u/ml
4.1
4.8
0.19
33
174
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
156
1185
1.33
2.95
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
106
1462
0.71
2.93
2.0
2.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
39
220
1.78
2.93
1.3
1.3
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
11
35
3.15
2.93
1.1
1.1
—
—
—
0
0
(4062490)
38
213
1.79
2.92
1.4
1.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
13
5.39
2.87
1.6
1.8
ng/l
208.6
146.2
—
7
13
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
9
6.68
2.87
1.5
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
89
2.26
2.86
1.8
1.5
u/l
0.9
3.8
—
8
44
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
67
441
1.53
2.80
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
31
165
1.89
2.80
1.1
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
39
224
1.75
2.78
1.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
638
5671
1.16
2.74
1.6
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
88
616
1.44
2.74
3.7
3.6
g/l
0.3
0.4
0.20
44
303
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
66
2.43
2.71
2.7
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
151
1949
0.76
2.70
1.6
1.6
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
37
212
1.75
2.67
1.4
1.3
g/l
0.3
0.4
0.53
27
142
(3028192) IgG subclass 2 [Mass/volume] in Serum
37
212
1.75
2.67
1.4
1.3
g/l
2.8
2.9
0.06
27
142
(3025130) Human papilloma virus identified in Specimen
73
496
1.48
2.65
1.7
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
12
43
2.80
2.64
1.1
1.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
37
213
1.75
2.63
1.4
1.3
g/l
5.7
6.6
1.59
27
145
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
67
2.40
2.63
2.7
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
65
432
1.52
2.62
1.2
1.3
u/ml
4.3
4.6
0.05
27
159
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
25
127
1.98
2.60
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
17
74
2.30
2.57
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
135
1029
1.33
2.54
3.0
4.2
ug/l
13.4
54.2
0.61
104
767
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
166
2095
0.78
2.51
1.4
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
99
721
1.39
2.49
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
105
773
1.37
2.48
1.4
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
16
69
2.33
2.48
1.0
1.0
mg/g
5.8
6.2
0.15
16
69
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
151
1.86
2.47
1.9
2.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
108
800
1.36
2.46
1.1
1.1
u/ml
2.4
2.5
0.02
30
222
(3017509) Phencyclidine [Presence] in Urine
12
45
2.67
2.45
2.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
168
2109
0.78
2.44
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
168
2107
0.79
2.43
1.4
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
67
457
1.48
2.41
1.2
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
168
2104
0.79
2.40
1.4
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
12
5.01
2.40
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
31
175
1.78
2.38
1.3
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
58
2.42
2.37
2.3
2.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
16
71
2.26
2.34
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
16
71
2.26
2.34
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
71
2.26
2.34
1.2
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
20
98
2.05
2.31
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
53
2.46
2.27
1.4
3.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
47
2.56
2.27
1.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1139
10625
1.12
2.26
4.2
3.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
42
654
0.64
2.25
1.8
1.6
mmol/l
7.9
7.3
1.05
26
407
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
18
3.90
2.25
1.1
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
52
342
1.53
2.24
1.3
1.2
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
61
0.00
2.23
0.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
743
6763
1.13
2.23
3.3
2.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
162
1291
1.27
2.22
2.4
2.2
ml/min/173m2
85.7
80.1
0.76
67
452
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
16
73
2.20
2.21
1.1
1.1
u/l
18.4
18.9
0.02
11
61
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
54
2.41
2.19
3.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
54
2.41
2.19
3.0
1.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
16
74
2.17
2.14
1.1
1.1
u/l
77.4
80.9
—
10
64
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
90
665
1.36
2.12
1.4
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
24
130
1.85
2.12
2.3
3.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
119
919
1.31
2.09
2.1
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
11
43
2.56
2.09
1.1
1.2
—
—
—
0
0
(4306422)
62
432
1.44
2.05
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
111
852
1.31
2.05
1.5
1.6
iu/ml
0.0
0.1
1.38
22
165
(3035320) C reactive protein [Mass/volume] in Body fluid
27
154
1.76
2.04
1.8
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
36
223
1.62
2.02
1.4
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
50
2.41
2.02
1.2
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
478
4254
1.15
2.02
2.6
2.3
umol/l
2279.2
4086.1
0.74
411
3865
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
24
133
1.81
1.99
1.3
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
30
178
1.69
1.98
2.2
2.4
%
40.8
43.4
—
5
22
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
24
134
1.80
1.95
1.1
1.1
%
98.0
87.8
1.33
19
109
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
51
2.36
1.95
1.2
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
28
164
1.71
1.94
1.1
1.3
u/ml
0.3
0.4
0.12
15
49
(21494814) CD8 cells/100 lymphocytes in Specimen
14
64
2.19
1.94
2.4
2.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
11
4.55
1.94
9.0
6.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
23
127
1.82
1.93
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
45
2.45
1.93
1.0
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
15
71
2.12
1.92
1.3
4.9
mg/l
45.6
71.0
—
10
51
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
39
2.57
1.92
1.1
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
56
389
1.45
1.90
1.1
1.1
iu/ml
10.1
3399.7
0.79
13
119
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
52
2.31
1.87
2.3
3.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
53
367
1.45
1.84
1.8
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
13
59
2.21
1.84
1.6
1.4
—
—
—
0
0
(44806071)
10
40
2.51
1.83
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
27
160
1.69
1.81
1.9
2.1
%
8.7
12.4
1.71
14
94
(3048879) Bone marrow aspiration report
7
23
3.05
1.80
1.3
2.4
—
—
—
0
0
(4094501)
52
361
1.45
1.79
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
24
139
1.73
1.75
1.1
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
18
3.34
1.74
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
26
155
1.68
1.72
2.8
2.5
e6/l
697.5
777.0
0.28
18
61
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
93
717
1.31
1.71
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
96
1.88
1.70
1.0
1.1
%
101.0
95.4
—
8
47
(3025018) Bordetella pertussis Ab [Titer] in Serum
27
164
1.65
1.68
1.3
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
22
126
1.75
1.68
1.2
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
53
375
1.42
1.67
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
39
260
1.51
1.65
1.3
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
17
90
1.89
1.65
1.0
1.1
%
104.3
96.2
—
8
43
(44806420)
5
14
3.58
1.61
2.2
2.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
161
1336
1.22
1.61
2.8
2.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
62
455
1.37
1.60
3.5
3.8
%
57.3
56.3
0.29
62
455
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
6
20
3.00
1.58
1.5
1.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
8
175
0.46
1.57
1.0
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
139
1685
0.82
1.56
1.4
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
64
474
1.36
1.56
2.2
2.3
mg/l
10.6
9.8
0.47
59
452
(3000034) Microalbumin [Mass/volume] in Urine
22
129
1.71
1.56
2.7
3.2
mg/l
7.7
50.8
1.69
11
91
(3002256) Pathology report gross observation
274
2391
1.16
1.55
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
144
1735
0.82
1.53
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
46
324
1.43
1.51
8.3
3.8
u/ml
0.4
0.3
0.05
27
166
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
21
2.86
1.50
9.7
3.1
umol/l
45.5
47.2
—
6
14
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
72
1.95
1.48
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
48
343
1.41
1.46
1.4
1.5
mmol/l
10.9
12.2
0.34
11
42
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
28
2.50
1.45
1.0
1.3
—
—
—
0
0
(4024509)
24
148
1.63
1.44
2.2
1.4
—
—
—
0
0
(4015189)
5
16
3.13
1.44
3.2
2.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
16
3.13
1.44
1.0
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
17
95
1.79
1.43
2.7
3.0
nmol/l
0.9
0.9
—
8
76
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
81
1.86
1.40
1.1
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
120
0.42
1.37
1.2
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
47
2.13
1.33
2.8
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
42
2.15
1.33
1.1
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
55
411
1.34
1.31
1.3
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
42
300
1.41
1.31
1.3
1.3
—
96.0
—
0
5
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
46
334
1.38
1.31
2.4
2.7
ug/min
50.0
116.7
0.74
30
217
(3030905) Polymorphonuclear cells [#/volume] in Blood
59
447
1.33
1.29
3.3
3.6
e9/l
4.2
4.0
0.28
59
447
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
177
1.53
1.28
1.4
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
142
1678
0.84
1.27
1.4
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
17
99
1.72
1.27
1.6
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
35
2.29
1.26
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
35
244
1.44
1.25
1.7
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
29
195
1.49
1.24
1.3
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
54
407
1.33
1.23
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
9
45
2.00
1.23
1.1
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
84
674
1.25
1.21
1.0
1.1
u/ml
5.2
4.6
0.10
38
280
(40757373) Influenza virus identified in Isolate
6
26
2.31
1.18
1.2
1.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
36
256
1.41
1.17
1.0
1.1
u/ml
0.5
3.0
1.09
15
87
(3019832) Treponema pallidum Ab [Presence] in Serum
733
6883
1.09
1.17
2.1
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
125
1.60
1.17
2.9
2.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
102
1.67
1.16
1.3
1.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
34
240
1.42
1.16
2.4
4.3
u/ml
24.8
78.6
—
5
80
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
39
2.05
1.15
1.1
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
40
2.00
1.12
2.9
2.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(4146454)
18
112
1.61
1.08
1.7
3.0
—
—
—
0
0
(3035880) pH of Pleural fluid
7
32
2.19
1.08
1.3
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
32
227
1.41
1.07
1.3
1.3
pmol/l
46.3
52.6
0.12
12
64
(3023430) Cat dander IgE Ab [Units/volume] in Serum
77
624
1.24
1.05
1.0
1.1
u/ml
7.6
6.3
0.14
38
271
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
195
1.44
1.04
1.1
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
11
60
1.84
1.02
1.6
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
71
573
1.25
1.01
1.2
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
32
231
1.39
0.99
2.7
2.4
mmol/l
1.4
1.4
0.06
32
226
(3045142) Bone marrow Pathology biopsy report
7
134
0.52
0.98
1.0
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
23
2.18
0.98
1.2
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
237
2126
1.12
0.97
4.1
3.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
36
1.95
0.97
1.9
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
32
0.00
0.95
0.0
5.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
77
1.69
0.95
1.2
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
20
133
1.51
0.94
1.2
1.4
e6/l
13015.9
77687.7
0.71
15
96
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
14
85
1.65
0.94
1.3
1.3
%
108.1
106.7
0.08
14
72
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
62
1.78
0.94
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
145
0.55
0.92
1.0
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
68
553
1.24
0.92
1.3
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
24
167
1.44
0.92
1.1
1.4
titre
356.7
293.5
—
9
34
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
24
167
1.44
0.92
1.1
1.4
—
250.0
—
0
6
(3008536) Aspergillus sp Ab [Presence] in Serum
6
28
2.15
0.91
2.8
2.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
28
2.15
0.91
1.0
1.3
—
—
—
0
0
(4035726)
148
1294
1.15
0.91
1.4
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
12
195
0.61
0.90
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
63
1.75
0.90
1.3
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
846
8862
0.94
0.89
1.6
1.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
29
2.07
0.89
1.3
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
29
2.07
0.89
1.3
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
10
169
0.59
0.88
10.0
6.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
10
169
0.59
0.88
5.0
3.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
53
422
1.26
0.87
4.8
3.0
mg/l
21.6
24.3
0.23
37
256
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
213
1915
1.12
0.86
2.2
2.4
ug/l
0.5
0.7
2.07
125
993
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
29
212
1.37
0.86
1.3
1.6
—
—
—
0
0
(44790047)
29
212
1.37
0.86
1.3
1.6
—
—
—
0
0
(44790049)
29
212
1.37
0.86
1.3
1.6
—
—
—
0
0
(44790048)
29
212
1.37
0.86
1.3
1.6
—
—
—
0
0
(44806118)
29
212
1.37
0.86
1.3
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
179
1.40
0.84
1.4
2.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
30
222
1.35
0.83
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
55
443
1.25
0.83
2.2
1.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
41
523
0.78
0.83
1.4
1.6
mmol/l
7.3
6.6
0.61
28
373
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
61
498
1.23
0.82
1.0
1.1
u/ml
2.5
2.6
0.08
26
276
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
45
566
0.79
0.81
1.4
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
26
189
1.38
0.81
1.2
1.2
ratio
1.1
1.0
—
7
82
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
130
1.46
0.80
1.6
1.5
%
25.9
38.2
0.92
13
86
(3039443) Prostate specific Ag panel - Serum or Plasma
23
317
0.72
0.80
1.2
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
98
1.53
0.78
1.9
1.8
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
47
376
1.25
0.77
1.2
2.7
nmol/l
1.2
0.8
2.43
40
319
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
107
1.50
0.76
1.2
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
98
845
1.17
0.75
2.1
2.5
umol/l
4.3
5.3
1.14
78
633
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
53
1.70
0.75
1.1
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
54
1.67
0.74
1.2
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
25
2.00
0.72
1.2
1.2
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
5
25
2.00
0.72
1.0
1.0
u/ml
0.1
0.3
—
5
20
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
40
1.75
0.71
4.7
5.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
31
238
1.31
0.70
2.0
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
64
539
1.19
0.67
1.0
1.0
u/ml
0.0
0.4
2.87
18
124
(3017569) Oxygen content in Arterial blood
7
43
1.63
0.66
1.3
3.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
14
94
1.49
0.66
2.9
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
79
1.52
0.62
1.3
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
8
49
1.63
0.62
1.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
18
130
1.39
0.61
1.7
2.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
18
130
1.39
0.61
1.1
1.1
u/ml
2.2
7.7
—
10
79
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
22
0.00
0.59
0.0
7.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
89
1.46
0.58
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
40
328
1.22
0.57
1.6
1.7
e6/l
9271.1
11738.5
0.19
33
255
(3009871) Measles virus Ab [Titer] in Serum
5
88
0.57
0.56
1.6
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
16
217
0.74
0.55
1.1
1.6
mmol/l
5.6
5.2
0.80
16
210
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
60
1.50
0.54
2.0
2.4
ug/l
72.6
78.5
—
9
60
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
66
1.52
0.52
2.8
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
56
651
0.86
0.52
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
31
381
0.81
0.52
3.1
1.6
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
47
397
1.19
0.51
1.4
1.4
nmol/l
31.9
31.8
0.00
41
362
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
62
714
0.87
0.51
2.2
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
135
1.34
0.51
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
27
215
1.26
0.51
1.4
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
6
41
1.46
0.50
1.5
2.7
e6/l
390.5
567.8
—
6
35
(3034426) Prothrombin time (PT)
13
93
1.40
0.48
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
15
200
0.75
0.47
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
102
1.37
0.47
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
89
799
1.12
0.45
2.9
2.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
57
652
0.87
0.45
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
104
1.35
0.43
1.1
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
42
359
1.17
0.42
1.3
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
32
1.56
0.42
1.2
7.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
32
267
1.20
0.42
1.0
1.1
u/ml
0.3
1.8
1.66
11
70
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
70
1.43
0.41
1.3
1.7
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
17
216
0.79
0.40
1.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
35
1.43
0.39
1.4
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
71
1.41
0.39
1.3
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
89
1.35
0.38
1.3
2.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
179
1.23
0.37
1.5
1.7
%
64.8
52.0
0.74
14
127
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
37
1.35
0.37
2.4
4.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2189
22090
0.96
0.37
4.3
3.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
116
0.69
0.37
8.1
1.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
70
1.29
0.36
1.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
9
70
1.29
0.36
1.1
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
135
1.26
0.35
1.1
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
125
0.72
0.35
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
199
1.21
0.35
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
44
1.36
0.34
1.7
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
109
1.29
0.33
3.2
1.5
—
—
—
0
0
(3000492) Spirometry study
252
2403
1.05
0.32
1.4
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
155
1.23
0.32
1.7
1.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
25
211
1.19
0.31
3.0
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
28
240
1.17
0.30
1.2
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
76
1.32
0.28
1.3
2.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
76
1.32
0.28
1.3
2.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
16
194
0.82
0.27
3.4
3.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
121
0.74
0.27
1.1
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
66
1.21
0.26
1.3
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
67
1.19
0.26
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
36
320
1.13
0.25
3.1
3.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
293
1.13
0.24
1.8
2.8
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
11
88
1.25
0.22
20.2
27.3
ug/l
99.3
123.4
—
6
72
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
40
1.25
0.22
27.4
3.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
41
1.22
0.22
2.8
5.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.2
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
12
0.00
0.21
0.0
4.7
—
439.9
—
0
12
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
134
0.82
0.20
1.6
1.3
—
—
—
0
0
(4281824)
14
166
0.84
0.20
1.3
1.1
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
113
0.80
0.20
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
109
1.19
0.18
4.2
4.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
153
0.85
0.18
1.3
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
62
1.13
0.17
1.1
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
68
0.73
0.17
1.4
1.3
ug/l
12.1
8.3
—
5
68
(3042733) HLA Ab [Presence] in Serum
8
73
1.10
0.15
3.0
5.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
20
223
0.90
0.14
2.4
3.7
u/ml
17.0
23.9
0.75
20
217
(3020650) Glucose [Presence] in Urine
7
90
0.78
0.14
1.9
1.3
—
—
—
0
0
(4211845)
10
118
0.85
0.14
2.8
2.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
110
0.82
0.13
1.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
125
1.12
0.10
4.3
7.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
42
442
0.95
0.09
1.3
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
116
1.12
0.09
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
68
1.03
0.07
1.4
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
24
225
1.07
0.07
1.5
1.4
—
—
—
0
0
(4133840)
8
78
1.03
0.07
1.3
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
148
1.08
0.06
2.6
3.9
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
27
258
1.05
0.04
1.0
1.0
u/ml
0.3
2.4
—
6
42
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
18
189
0.95
0.03
1.2
1.1
miu/ml
1594.0
1457.8
0.20
18
189
(40765089) Chromosome analysis panel - Blood by G-banded
23
221
1.04
0.03
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
38
370
1.03
0.03
1.3
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
12
128
0.94
0.02
2.6
2.6
%
38.2
43.2
—
5
42
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
33
322
1.03
0.01
1.1
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
13
123
1.06
0.01
1.7
2.2
u/field
1.1
2.1
—
7
70
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
108
1086
0.99
0.00
1.8
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
10
105
0.95
0.00
2.8
2.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
18
175
1.03
0.00
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
14
141
0.99
0.00
1.9
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
27
271
1.00
0.00
1.6
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
45
451
1.00
0.00
1.8
1.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
7
75
0.93
0.00
1.1
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
7
75
0.93
0.00
1.1
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
7
75
0.93
0.00
1.1
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
33.3
—
0
7
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
35.7
—
0
6
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
8
0.00
0.00
0.0
3.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
64
0.94
0.00
3.2
2.8
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
110
1.00
0.00
1.0
2.6
ug/l
26.7
301.0
0.66
11
100
(3016135) IgD [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
34.6
—
0
5
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
18.4
—
0
5
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
113.8
—
0
6
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047185) IgG [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
4.3
—
0
6
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
7
71
0.99
0.00
1.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_OCD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_OCD | 1.938 [1.63, 2.3] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.116 |
During the follow-up period (1.1.1998 — 31.12.2019), 472 out of 12309 females with F5_OCD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_OCD | 1.986 [1.7, 2.32] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 518 out of 9308 males with F5_OCD died.
Mortality risk
Mortality risk for people of age
years, who have F5_OCD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.158% | 0.356% |
| 5 | 0.983% | 2.309% |
| 10 | 2.729% | 5.583% |
| 15 | 4.791% | 10.558% |
| 20 | 8.618% | 18.104% |
Relationships between endpoints
↥Index endpoint: F5_OCD – Obsessive-compulsive disorder
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data